[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 175
1. Krause E, Gürkov R, Klauss V: [Solitary fibrous tumor in the orbit. Case report and review of the literature]. HNO; 2009 Feb;57(2):169-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Solitary fibrous tumor in the orbit. Case report and review of the literature].
  • [Transliterated title] Solitärer fibröser Tumor in der Orbita. Fallbericht und Literaturübersicht.
  • BACKGROUND: Solitary fibrous tumor (SFT) is a mesenchymal neoplasm with a benign growth behavior.
  • Tumor growth over 7 years led to a severe exophthalmos with loss of vision.
  • CONCLUSION: SFT is a rare differential diagnosis of orbital lesions and can be appropriately treated by surgical resection.
  • [MeSH-major] Blindness / etiology. Blindness / prevention & control. Orbital Neoplasms / complications. Orbital Neoplasms / surgery. Solitary Fibrous Tumors / complications. Solitary Fibrous Tumors / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eye (Lond). 2001 Feb;15(Pt 1):102-4 [11318269.001]
  • [Cites] Neuropathology. 2006 Dec;26(6):557-63 [17203593.001]
  • [Cites] Int J Oral Maxillofac Surg. 2005 May;34(3):331-3 [15741045.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1241-5 [11846919.001]
  • [Cites] HNO. 2006 Dec;54(12):962-6 [16477466.001]
  • [Cites] HNO. 2007 Apr;55(4):287-92 [16622693.001]
  • [Cites] Am J Surg Pathol. 1998 Dec;22(12 ):1501-11 [9850176.001]
  • [Cites] J Thorac Cardiovasc Surg. 1978 Mar;75(3):363-72 [633933.001]
  • [Cites] Histopathology. 2006 Jan;48(1):3-12 [16359532.001]
  • [Cites] Eye (Lond). 1996;10 ( Pt 3):396-9 [8796170.001]
  • [Cites] Orbit. 2006 Mar;25(1):45-50 [16527776.001]
  • [Cites] Cancer. 2002 Feb 15;94(4):1057-68 [11920476.001]
  • [Cites] Korean J Radiol. 2005 Jul-Sep;6(3):136-42 [16145288.001]
  • [Cites] Can J Ophthalmol. 1997 Dec;32(7):432-5 [9435973.001]
  • [Cites] Virchows Arch. 1997 Jun;430(6):445-53 [9230909.001]
  • [Cites] Am J Surg Pathol. 2001 Nov;25(11):1424-8 [11684960.001]
  • [Cites] Surv Ophthalmol. 2003 Sep-Oct;48(5):544-54 [14499820.001]
  • (PMID = 19221826.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 18
  •  go-up   go-down


2. Randriamora JT, Andrianilana H, Rarivomanana M, Raherizaka N, Rakotovao F, Rasoavelonoro VA: [Voluminous mucocele of frontal sinus with superior eyelid and orbit expansion]. J Fr Ophtalmol; 2005 Jan;28(1):55-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: A mucocele is an unusual benign cystic tumor, frequently seen in the adult and affecting mucous sinuses that expand the orbit by bone destruction.
  • DESCRIPTION: A 72-year-old man, without a history of sinus disease, presented a voluminous mucocele of the right frontal sinus that had begun 3 years before, with superior eyelid and orbit expansion hiding and pushing the eye to the downside and the outside.
  • After surgery, the patient recovered visual function without diplopia, and normal eyelid and ocular motility.
  • However, the right eye is abnormally sized a bit downside.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15767900.001).
  • [ISSN] 0181-5512
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


3. Soni CR, Kumar G, Sahota P, Miller DC, Litofsky NS: Metastases to Meckel's cave: report of two cases and comparative analysis of malignant tumors with meningioma and schwannoma of Meckel's cave. Clin Neurol Neurosurg; 2010 Dec;112(10):927-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We analyzed the symptoms, results of neurological and radiographic examination, pre-operative diagnosis and final diagnosis of these tumors.
  • RESULTS: Of the 21 patients with malignant tumor involving Meckel's cave, 76% (16/21) had pain, 67% (14/21) had paraesthesia, 89% (17/21) had objective evidence of trigeminal sensory involvement and 42% (8/21) had objective evidence of trigeminal motor involvement.
  • CONCLUSION: Subtle clinical clues may help differentiate malignant from benign involvement of Meckel's cave.
  • [MeSH-major] Meningioma / secondary. Meningioma / surgery. Neurilemmoma / secondary. Neurilemmoma / surgery. Skull Base Neoplasms / secondary. Skull Base Neoplasms / surgery. Temporal Bone / pathology
  • [MeSH-minor] Aged. Carcinoma, Squamous Cell / pathology. Craniotomy. Diagnosis, Differential. Fatal Outcome. Female. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Middle Aged. Nose Neoplasms / pathology

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 20728984.001).
  • [ISSN] 1872-6968
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


Advertisement
4. Yates CW, Weinberg M, Packer MJ, Jacob A: Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma. Ann Otol Rhinol Laryngol; 2010 Jun;119(6):402-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma.
  • Vestibular schwannomas are benign neoplasms that arise from Schwann cells of the eighth cranial nerve.
  • During this procedure, a biopsy specimen was obtained, showing benign vestibular schwannoma.

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. WARFARIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20583739.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 5Q7ZVV76EI / Warfarin
  •  go-up   go-down


5. Gil Z, Abergel A, Leider-Trejo L, Khafif A, Margalit N, Amir A, Gur E, Fliss DM: A comprehensive algorithm for anterior skull base reconstruction after oncological resections. Skull Base; 2007 Feb;17(1):25-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: One hundred nine patients who had undergone 120 anterior skull base resections of tumors (52 malignant [43%], 68 benign [57%]) via the subcranial approach were studied.
  • A split calvarial bone graft, posterior frontal sinus wall, or three-dimensional titanium mesh were used when the tumor involved the frontal, nasal, or orbital bones.
  • A temporalis muscle flap was used to cover the orbital socket for cases of eye globe exenteration, and a rectus abdominis free flap was used for subcranial-orbitomaxillary resection.
  • We describe a simple and effective method of anterior skull base reconstruction after resections of both malignant and benign tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol Head Neck Surg. 1993 Apr;119(4):385-93 [8457302.001]
  • [Cites] Neurosurgery. 1996 Mar;38(3):471-9; discussion 479-80 [8837798.001]
  • [Cites] Plast Reconstr Surg. 1996 Dec;98(7):1159-66; discussion 1167-8 [8942901.001]
  • [Cites] Neurosurgery. 1998 Mar;42(3):455-61; discussion 461-2 [9526977.001]
  • [Cites] J Surg Oncol. 1998 Dec;69(4):275-84 [9881946.001]
  • [Cites] Scand J Plast Reconstr Surg Hand Surg. 2000 Mar;34(1):43-53 [10756575.001]
  • [Cites] J Neurosurg. 2002 Feb;96(2):280-6 [11838802.001]
  • [Cites] Head Neck. 2003 Feb;25(2):89-96 [12509790.001]
  • [Cites] Plast Reconstr Surg. 2005 Aug;116(2):395-8; discussion 399 [16079662.001]
  • [Cites] Laryngoscope. 1990 Jun;100(6):607-14 [2348740.001]
  • [Cites] Science. 1987 Jan 23;235(4787):442-7 [2432664.001]
  • [Cites] Head Neck Surg. 1988 Mar-Apr;10(4):219-24 [3235351.001]
  • [Cites] J Neurosurg. 1984 Feb;60(2):408-9 [6198497.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1995 Nov;121(11):1253-7 [7576471.001]
  • [Cites] Neurosurgery. 1995 Apr;36(4):725-9; discussion 729-31 [7596503.001]
  • [Cites] J Neurosurg. 1995 Jun;82(6):1002-10 [7760173.001]
  • [Cites] Plast Reconstr Surg. 1994 Nov;94(6):794-800 [7972424.001]
  • (PMID = 17603642.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1852574
  •  go-up   go-down


6. Schalenbourg A, Uffer S, Zografos L: Utility of a biopsy in suspicious pigmented iris tumors. Ophthalmic Res; 2008;40(5):267-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In the presence of pigmented iris lesions evocative of malignant melanoma and implying oncological treatment, a foregoing biopsy to exclude a benign lesion may seem a reasonable approach.
  • MATERIAL AND METHODS: Retrospective, consecutive histopathologic case series of 10 pigmented iris tumor specimens excised since 1993.
  • Histopathologic diagnosis was compared with final diagnosis and outcome in the patient's medical chart.
  • RESULTS: Five biopsies had only nevus cells, whereas ulterior clinical data or histopathologic examinations were compatible with the diagnosis of malignant melanoma.
  • [MeSH-major] Iris Neoplasms / pathology. Melanoma / pathology. Nevus, Pigmented / pathology
  • [MeSH-minor] Adult. Biopsy. Eye Enucleation. Female. Humans. Iridectomy. Male. Microscopy, Acoustic. Middle Aged. Protons. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel.
  • (PMID = 18437037.001).
  • [ISSN] 1423-0259
  • [Journal-full-title] Ophthalmic research
  • [ISO-abbreviation] Ophthalmic Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


7. Murthy R, Honavar SG: Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1. J AAPOS; 2009 Feb;13(1):97-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1.
  • Vasoproliferative retinal tumors are benign tumors of unknown origin that generally affect healthy persons between their fourth and sixth decades and may lead to severe vision loss as a result of intraretinal hemorrhages and exudates.
  • We describe a case of unilateral vasoproliferative retinal tumor associated with retinitis pigmentosa in a patient with Usher syndrome type 1.


8. Kashkouli MB, Khalatbari MR, Yahyavi T, Borghei Razavi H, Shayanfar N, Parvaresh MM: Primary endo-orbital osteoid osteoma. Orbit; 2008;27(3):211-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteiod osteoma is a small, benign, osteoblastic tumor, which usually affects the long bone of the lower extremities and vertebrae.
  • A 22-year-old man presented with eyelid edema, proptosis and pain in the left eye 1 year after the beginning of the symptoms.
  • [MeSH-major] Orbital Neoplasms / pathology. Orbital Neoplasms / surgery. Osteoma, Osteoid / pathology. Osteoma, Osteoid / surgery
  • [MeSH-minor] Adult. Biopsy, Needle. Exophthalmos / diagnosis. Exophthalmos / etiology. Follow-Up Studies. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Neoplasm Staging. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18569832.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


9. Arora R, Monga S, Mehta DK, Raina UK, Gogi A, Gupta SD: Malignant fibrous histiocytoma of the conjunctiva. Clin Exp Ophthalmol; 2006 Apr;34(3):275-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They can occur in any part of the body including the orbital tissues.
  • Eleven of these were classified as benign, and the rest were malignant fibrous histiocytomas.
  • Benign fibrous histiocytomas have been reported in the orbit, eyelid, episclera and conjunctiva.
  • Malignant fibrous histiocytoma has been well described in the orbit, but rarely as a primary conjunctival tumour.
  • The rarity of the tumour makes its diagnosis and management a challenge.
  • Herein, the clinicopathological features of a case of malignant fibrous histiocytoma are presented and its management with wide excision and cryotherapy followed by ocular reconstruction with amniotic membrane transplant is discussed.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Histiocytoma, Malignant Fibrous / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Humans. Male. Middle Aged. Neoplasm Proteins / metabolism

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16671910.001).
  • [ISSN] 1442-6404
  • [Journal-full-title] Clinical & experimental ophthalmology
  • [ISO-abbreviation] Clin. Experiment. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


10. Kiratli H, Bulur B, Bilgiç S: Transconjunctival approach for retrobulbar intraconal orbital cavernous hemangiomas. Orbital surgeon's perspective. Surg Neurol; 2005 Jul;64(1):71-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Cavernous hemangioma is the most common benign intraorbital tumor found in adults.
  • The presumptive preoperative diagnosis was based on magnetic resonance imaging findings.
  • The tumor was exposed via a transconjunctival route after temporarily disinserting an extraocular muscle depending on the location of the lesion.
  • RESULTS: In all patients, the tumor was in touch with the globe and in most cases extended to the orbital apex.
  • This method is best for tumors whose anterior borders are in contact or very close to the eye even if the posterior border abuts the orbital apex.
  • [MeSH-major] Hemangioma, Cavernous / surgery. Neurosurgical Procedures / methods. Orbital Neoplasms / surgery

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Surg Neurol. 2006 Mar;65(3):316; author reply 316 [16488268.001]
  • (PMID = 15993191.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Ferlito A, Elsheikh MN, Manni JJ, Rinaldo A: Paraneoplastic syndromes in patients with primary head and neck cancer. Eur Arch Otorhinolaryngol; 2007 Mar;264(3):211-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Paraneoplastic syndromes represent the clinical manifestations of the indirect and remote effects produced by tumor metabolites or other products.
  • Paraneoplastic syndromes related to primary malignancies of the head and neck region can be categorized as: endocrine, cutaneous or dermatologic, hematologic, neurologic, osteoarticular or rheumatologic, ocular syndromes.
  • Sometimes, paraneoplastic syndromes can be more serious than the consequences of the primary tumor itself and can precede, follow or be concurrent to the diagnosis of a malignancy; moreover, they can dominate the clinical picture and thus lead to errors with respect to the origin and type of the primary tumor.
  • Physicians who deal with cancer-associated syndromes should be able to differentiate the paraneoplastic syndromes from the benign disorders that mimic them.
  • Patients with a suspected paraneoplastic disorder should undergo a complete panel of laboratory studies, in addition to imaging studies and endoscopy.
  • Identification of paraneoplastic syndromes allow the clinician to make an early diagnosis and to provide adequate treatment of tumors, with a favorable oncologic outcome and improved life expectancy for the patient.
  • These syndromes can follow the clinical course of the tumor and thus be useful for monitoring its evolution.
  • [MeSH-major] Chorionic Gonadotropin, beta Subunit, Human / metabolism. Head and Neck Neoplasms. Paraneoplastic Syndromes

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2003 Jul;34(7):717-9 [12874770.001]
  • [Cites] J Laryngol Otol. 1997 Jan;111(1):66-9 [9292137.001]
  • [Cites] Z Hautkr. 1986 Sep 1;61(17):1229-37 [3776278.001]
  • [Cites] Cutis. 2004 Nov;74(5):289-92 [15605965.001]
  • [Cites] Otolaryngol Head Neck Surg. 1995 Jan;112(1):125-7 [7816446.001]
  • [Cites] Brain. 1997 Aug;120 ( Pt 8):1279-300 [9278623.001]
  • [Cites] N Y State J Med. 1954 Aug 15;54(16):2333-6 [13194110.001]
  • [Cites] Dermatologica. 1990;180(4):212-6 [2192925.001]
  • [Cites] Cancer. 1995 Apr 1;75(7):1678-83 [8826927.001]
  • [Cites] Reumatismo. 2002;54(1):48-51 [12089614.001]
  • [Cites] Surv Ophthalmol. 2003 Jan-Feb;48(1):12-38 [12559325.001]
  • [Cites] J Otolaryngol. 1994 Dec;23(6):437-9 [7897775.001]
  • [Cites] Oral Oncol. 2005 Oct;41(9):878-83 [16154516.001]
  • [Cites] Presse Med. 1985 Feb 23;14(8):471-4 [3157147.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2006 Jan;263(1):32-6 [15986184.001]
  • [Cites] Ann Neurol. 2001 Feb;49(2):146-54 [11220734.001]
  • [Cites] J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1980 Mar;29(3):165-9, 171-2 [6449549.001]
  • [Cites] Gynecol Oncol. 1999 Jun;73(3):430-2 [10366473.001]
  • [Cites] Metabolism. 1976 Jun;25(6):697-721 [818477.001]
  • [Cites] Thyroid. 2005 Jun;15(6):618-23 [16029131.001]
  • [Cites] Head Neck. 2006 Dec;28(12):1142-6 [16721738.001]
  • [Cites] Otolaryngol Head Neck Surg. 1998 Mar;118(3 Pt 1):412-4 [9527129.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Apr;32(2):174-80 [12729778.001]
  • [Cites] J Neuroophthalmol. 2001 Sep;21(3):173-87 [11725182.001]
  • [Cites] Am J Ophthalmol. 2001 Aug;132(2):273-5 [11476700.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Dec;117(6):S239-42 [9419160.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1973 Apr-May;90(4):314-7 [4753178.001]
  • [Cites] Bone. 1991;12 (4):237-9 [1793672.001]
  • [Cites] Medicine (Baltimore). 1991 Jul;70(4):269-80 [2067411.001]
  • [Cites] J Otolaryngol. 2004 Oct;33(5):308-9 [15931816.001]
  • [Cites] Rev Neurol (Paris). 1989;145(12):851-2 [2616969.001]
  • [Cites] Am J Med. 1995 Dec;99(6):662-71 [7503090.001]
  • [Cites] Am J Med. 1986 Nov;81(5):946 [3777004.001]
  • [Cites] Ann Ital Med Int. 2005 Jan-Mar;20(1):28-38 [15859392.001]
  • [Cites] Ann Rheum Dis. 1992 Apr;51(4):556-7 [1586262.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1996 Jun;105(6):487-9 [8638903.001]
  • [Cites] Br J Dermatol. 1981 Jul;105(1):65-9 [7020742.001]
  • [Cites] Oral Oncol. 1998 Nov;34(6):567-70 [9930372.001]
  • [Cites] Thyroid. 2003 Jun;13(6):601-5 [12930605.001]
  • [Cites] Med Pediatr Oncol. 1993;21(9):676-9 [8413003.001]
  • [Cites] J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1978 May;27(5):353-7 [149835.001]
  • [Cites] Acta Pathol Jpn. 1985 Jul;35(4):915-23 [2416185.001]
  • [Cites] Head Neck Surg. 1982 Nov-Dec;5(2):125-9 [7169331.001]
  • [Cites] Ann Dermatol Venereol. 1981;108(11):885-8 [7325521.001]
  • [Cites] Cancer. 1996 May 15;77(10):1967-72 [8640657.001]
  • [Cites] Australas J Dermatol. 2000 Aug;41(3):178-80 [10954991.001]
  • [Cites] HNO. 2003 Apr;51(4):328-31 [12682736.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1987 May-Jun;96(3 Pt 1):315-21 [3300506.001]
  • [Cites] Geriatrics. 1963 Oct;18:745-53 [14072774.001]
  • [Cites] Australas Radiol. 2001 Feb;45(1):71-3 [11259979.001]
  • [Cites] Head Neck. 2004 Jan;26(1):89-93 [14724912.001]
  • [Cites] J Clin Oncol. 1993 Dec;11(12 ):2434-42 [8246032.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2001 Jan;110(1):76-82 [11201814.001]
  • [Cites] Rev Med Interne. 1988 Jan-Feb;9(1):81-4 [3368665.001]
  • [Cites] Arch Otolaryngol. 1984 Feb;110(2):123-6 [6320786.001]
  • [Cites] Arch Dermatol. 1979 Jun;115(6):734-5 [453878.001]
  • [Cites] Otolaryngol Head Neck Surg. 1995 Sep;113(3):301-4 [7675496.001]
  • [Cites] Acta Otorrinolaringol Esp. 1995 Jan-Feb;46(1):67-70 [7734170.001]
  • [Cites] Laryngoscope. 2006 Oct;116(10):1930-3 [17003734.001]
  • [Cites] Otolaryngol Head Neck Surg. 1992 Sep;107(3):475-7 [1408240.001]
  • [Cites] Cancer. 1996 May 1;77(9):1759-67 [8646671.001]
  • [Cites] N Z Med J. 2006 Jun 02;119(1235):U2006 [16751829.001]
  • [Cites] Singapore Med J. 1991 Apr;32(2):170-3 [2042083.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(4):205-10 [9592679.001]
  • [Cites] J Drugs Dermatol. 2004 Sep-Oct;3(5):557-9 [15552609.001]
  • [Cites] Oral Oncol. 2004 Jul;40(6):553-62 [15063382.001]
  • [Cites] An Sist Sanit Navar. 2005 May-Aug;28(2):213-26 [16155618.001]
  • [Cites] Laryngol Rhinol Otol (Stuttg). 1976 May;55(5):414-9 [135167.001]
  • [Cites] BMC Ophthalmol. 2004 Jun 04;4:5 [15180904.001]
  • [Cites] Arthritis Rheum. 1987 Jul;30(7):825-9 [3040016.001]
  • [Cites] J Am Acad Dermatol. 1987 Jun;16(6):1179-82 [3597859.001]
  • [Cites] Respiration. 1989;55(3):186-8 [2813976.001]
  • [Cites] Eye (Lond). 2002 Jul;16(4):501-3 [12101466.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1991 Apr;100(4 Pt 1):341-4 [2018296.001]
  • [Cites] Ophthalmology. 2002 Nov;109(11):2149-53 [12414431.001]
  • [Cites] Neoplasma. 1984;31(2):231-6 [6717693.001]
  • [Cites] Acta Otorrinolaringol Esp. 1998 Jun-Jul;49(5):414-5 [9717335.001]
  • [Cites] J Assoc Physicians India. 2003 Oct;51:1023-4 [14719600.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1992;230(4):324-8 [1505762.001]
  • [Cites] Laryngoscope. 1995 Aug;105(8 Pt 1):789-94 [7630288.001]
  • [Cites] Br J Dermatol. 1964 Aug-Sep;76:349-56 [14201182.001]
  • [Cites] Ophthalmic Genet. 2006 Jun;27(2):57-61 [16754207.001]
  • [Cites] Auris Nasus Larynx. 1989;16(2):127-32 [2552973.001]
  • [Cites] Ann Dermatol Venereol. 2006 Jun-Jul;133(6-7):557-60 [16885844.001]
  • [Cites] J R Nav Med Serv. 1967 Summer;53(2):75-8 [6046981.001]
  • [Cites] Lung Cancer. 1998 Nov;22(2):149-52 [10022222.001]
  • [Cites] Cutis. 2003 Nov;72(5):399-402 [14655782.001]
  • [Cites] J Dermatol. 2005 Aug;32(8):650-3 [16334866.001]
  • [Cites] Hautarzt. 1999 Mar;50(3):198-202 [10231690.001]
  • [Cites] HNO. 2003 Apr;51(4):332-6 [12682737.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1994;251(3):183-5 [8080640.001]
  • [Cites] Am J Otolaryngol. 1994 Sep-Oct;15(5):336-43 [7978037.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2000 Jan;109(1):109-17 [10651424.001]
  • [Cites] Cancer. 1975 May;35(5):1430-7 [164276.001]
  • [Cites] Curr Opin Neurol. 2005 Jun;18(3):331-6 [15891421.001]
  • [Cites] Semin Diagn Pathol. 1989 Nov;6(4):329-50 [2692106.001]
  • [Cites] Med Klin. 1969 Aug 15;64(33):1470-5 [5805799.001]
  • [Cites] Laryngoscope. 1990 Dec;100(12):1323-5 [2243527.001]
  • [Cites] Otolaryngol Head Neck Surg. 2002 Oct;127(4):354-6 [12402019.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1977 Jan-Feb;94(1-2):47-52 [855978.001]
  • [Cites] Medicine (Baltimore). 1977 Jan;56(1):1-37 [834136.001]
  • [Cites] Head Neck. 1997 Dec;19(8):701-5 [9406749.001]
  • [Cites] Mund Kiefer Gesichtschir. 2002 Sep;6(5):331-5 [12448236.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1997 Oct;106(10 Pt 1):878-83 [9342988.001]
  • [Cites] Ann Dermatol Venereol. 1992;119(6-7):483-5 [1444109.001]
  • [Cites] Otolaryngol Head Neck Surg. 1989 Jun;100(6):583-7 [2546116.001]
  • [Cites] Acta Otorrinolaringol Esp. 1999 Jun-Jul;50(5):405-9 [10491480.001]
  • [Cites] Laryngoscope. 1993 Jul;103(7):754-61 [8341101.001]
  • [Cites] Am J Clin Oncol. 1990 Oct;13(5):388-93 [2220659.001]
  • [Cites] Acta Otolaryngol. 2001 Sep;121(6):756-8 [11678176.001]
  • [Cites] Arch Neurol. 1999 Apr;56(4):405-8 [10199327.001]
  • [Cites] AJR Am J Roentgenol. 1977 Apr;128(4):679-81 [403806.001]
  • [Cites] Am Fam Physician. 1991 Oct;44(4):1325-9 [1927845.001]
  • [Cites] J Neurol. 2002 Jun;249(6):745-53 [12111309.001]
  • [Cites] J Am Acad Dermatol. 1989 Dec;21(6):1317 [2584473.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1979 Jun;96(6):349-58 [507641.001]
  • [Cites] Cancer. 1993 Nov 1;72(9):2723-31 [8402496.001]
  • [Cites] Rheumatol Int. 2003 Nov;23(6):309-11 [12838366.001]
  • [Cites] J Laryngol Otol. 1988 Feb;102(2):184-6 [3346603.001]
  • [Cites] Curr Opin Neurol. 2004 Feb;17(1):3-8 [15090871.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1992 Nov;101(11):946-9 [1332568.001]
  • (PMID = 17206403.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human
  • [Number-of-references] 126
  •  go-up   go-down


12. Farmer JP, Lamba M, McDonald H, Commons AS: Orbital giant cell angiofibroma: immuno-histochemistry and differential diagnosis. Can J Ophthalmol; 2006 Apr;41(2):216-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orbital giant cell angiofibroma: immuno-histochemistry and differential diagnosis.
  • COMMENTS: Giant cell angiofibroma is a benign spindle cell neoplasm characterized by multinucleated giant cells and pseudovascular spaces with a propensity to occur in the anterior soft tissues of the orbit of middle-aged adults.
  • It is part of a wide differential diagnosis of tumours that can be separated by various histologic and immunohistochemical features, which are discussed in the report.
  • It is important to consider it preoperatively because the vascular nature of this tumour may create problems with hemostasis during excision.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16767212.001).
  • [ISSN] 0008-4182
  • [Journal-full-title] Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
  • [ISO-abbreviation] Can. J. Ophthalmol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


13. Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS: Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Ophthalmology; 2007 Apr;114(4):774-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
  • METHODS: Evaluation of a large sibship via family history, complete eye and skin examinations, environmental risk factor questionnaire, and genetic testing, as well as a MEDLINE search of familial uveal melanoma kindreds.
  • MAIN OUTCOME MEASURES: Cutaneous and ocular nevi, benign and malignant neoplasms of skin and other sites, brief skin cancer risk assessment tool risk classification for cutaneous melanoma, DNA sequencing of p16INK4a and p14ARF genes, and citations on familial uveal melanoma.
  • No germline mutations were detected in the melanoma-associated tumor suppressor genes p16INK4a and p14ARF.
  • Seven out of 10 siblings had a history of cutaneous and/or ocular nevi.
  • Of the 3 subjects without nevi, 2 had histories of eye or skin malignancies (1 uveal melanoma, 1 basal cell carcinoma).
  • Three of the 10 siblings had relevant ocular findings (2 choroidal nevi, 1 uveal melanoma).
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Melanoma / genetics. Nevus, Pigmented / genetics. Skin Neoplasms / genetics. Uveal Neoplasms / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cyclin-Dependent Kinase Inhibitor p16 / genetics. DNA, Neoplasm / analysis. Female. Humans. Male. Middle Aged. Pedigree. Risk Factors. Sequence Analysis, DNA. Surveys and Questionnaires. Tumor Suppressor Protein p14ARF / genetics


14. Hajji Z, Charif Chefchaouni M, Chaoui Z, Agnaou L, Berraho A: [Diagnostic difficulties in pigmented tumor of the optic nerve head. A case report]. J Fr Ophtalmol; 2005 Jun;28(6):614-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic difficulties in pigmented tumor of the optic nerve head. A case report].
  • [Transliterated title] Difficultés diagnostiques face à une tumeur papillaire pigmentée. A propos d'un cas.
  • Melanocytoma of the optic disc is a benign pigmented tumor located on the optic nerve head.
  • We present a case of melanocytoma in a 49-year-old woman who presented with decreased vision in her left eye.
  • The tumor was stationary for 20 months.
  • Unusual features of melanocytoma (superior nasal location in the optic disc with an adjacent choroidal component, a decrease in visual acuity and disc edema surrounding the tumor) are discussed.
  • [MeSH-major] Carcinoma, Papillary / diagnosis. Eye Neoplasms / diagnosis. Melanoma / diagnosis. Nevus, Pigmented / diagnosis. Optic Nerve Neoplasms / diagnosis. Pigmentation Disorders / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Fluorescein Angiography. Humans. Melanocytes / pathology. Middle Aged

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Pigmentation Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16141925.001).
  • [ISSN] 0181-5512
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


15. Naik VR, Wan Faiziah WA, Musa MY: Choristoma of the base of the tongue. Indian J Pathol Microbiol; 2009 Jan-Mar;52(1):86-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Choristoma is a benign tumor where new bone formation occurs.
  • These choristomas can rarely occur in soft tissues especially in the head, eye, tongue, or extremities.
  • [MeSH-major] Choristoma / diagnosis. Choristoma / pathology. Tongue / pathology. Tongue Neoplasms / diagnosis. Tongue Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Indian J Pathol Microbiol. 2010 Apr-Jun;53(2):373 [20551565.001]
  • (PMID = 19136792.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


16. Berman EL, Shields CL, Sagoo MS, Eagle RC Jr, Shields JA: Multifocal blue nevus of the conjunctiva. Surv Ophthalmol; 2008 Jan-Feb;53(1):41-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Blue nevus is a congenital benign melanocytic tumor that classically occurs in the skin and carries low potential for malignant transformation.
  • A 55-year-old Hispanic woman was found to have multiple darkly pigmented lesions on her left eye.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Nevus, Blue / pathology
  • [MeSH-minor] Biopsy. Cryosurgery / methods. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Melanoma / diagnosis. Middle Aged

  • Genetic Alliance. consumer health - Nevus.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18191656.001).
  • [ISSN] 0039-6257
  • [Journal-full-title] Survey of ophthalmology
  • [ISO-abbreviation] Surv Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


17. Turell ME, Singh AD: Vascular tumors of the retina and choroid: diagnosis and treatment. Middle East Afr J Ophthalmol; 2010 Jul;17(3):191-200
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vascular tumors of the retina and choroid: diagnosis and treatment.
  • The major vascular tumors of the retina include retinal capillary hemangioma, cavernous hemangioma of the retina, retinal vasoproliferative tumor, and racemose hemangiomatosis of the retina or Wyburn-Mason syndrome.
  • While classified as benign, visual symptoms secondary to exudative retinal detachment and a variety of other mechanisms are common and are a major source of long-term visual disability.
  • As ocular symptoms are often the most common presenting disease manifestation, the ophthalmologist plays an important role in accurate and early diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20844673.001).
  • [ISSN] 0975-1599
  • [Journal-full-title] Middle East African journal of ophthalmology
  • [ISO-abbreviation] Middle East Afr J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2934709
  • [Keywords] NOTNLM ; Cavernous Hemangioma / Choroidal Hemangioma / Retinal Capillary Hemangioma / Retinal Vasoproliferative Tumor / Wyburn–Mason Syndrome
  •  go-up   go-down


18. Liao Y, Zeng H, Wang X, Huang Y, Chen N, Ge B, Tang L, Luo Q: Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland. Exp Eye Res; 2009 Jan;88(1):4-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenoid cystic carcinoma (ACC) of lachrymal gland is a malignant tumor with a poor prognosis, while, pleomorphic adenoma (PA) is the benign tumor of lachrymal gland epithelia.
  • Livin expression was almost undetectable in both malignancy and benign lesion of lachrymal gland.
  • Overexpression of Survivin in ACC was associated with poorer survival, which may have clinical impact on diagnosis and therapeutic considerations of this malignancy.
  • [MeSH-major] Adenoma, Pleomorphic / metabolism. Biomarkers, Tumor / metabolism. Carcinoma, Adenoid Cystic / metabolism. Inhibitor of Apoptosis Proteins / metabolism. Lacrimal Apparatus Diseases / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Gene Expression. Humans. Middle Aged. Neoplasm Proteins / metabolism. Neoplasm Staging. Paraffin Embedding. Prognosis. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods. Survival Analysis. Young Adult

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18955046.001).
  • [ISSN] 1096-0007
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Inhibitor of Apoptosis Proteins; 0 / Neoplasm Proteins; 0 / RNA, Messenger
  •  go-up   go-down


19. Kazakov AA, Grishina EE, Tarantul VZ, Gening LV: Effect of human cell malignancy on activity of DNA polymerase iota. Biochemistry (Mosc); 2010 Jul;75(7):905-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To clarify the possible role of incorrect DNA polymerase iota (Pol iota) function in increased frequency of mutations in mammalian cells, the activity of this enzyme in extracts of cells of different mouse organs and human eye (melanoma) and eyelid (basal-cell skin carcinoma) tumor cells was studied.
  • In the presence of Mn2+ the Pol iota activity in the basal-cell carcinoma exceeded 2.5-fold that in control cells (benign tumors from the same eyelid region).
  • In extracts of melanoma cells in the presence of either cation, the level of the enzyme activity was approximately equal to that in extracts of cells of surrounding tumor-free tissues as well as in eyes removed after traumas.
  • [MeSH-major] Carcinoma, Basal Cell / enzymology. DNA-Directed DNA Polymerase / metabolism. Eye Neoplasms / enzymology. Lymphoma, B-Cell, Marginal Zone / enzymology. Melanoma / enzymology
  • [MeSH-minor] Animals. Cell Line, Tumor. Enzyme Activation / drug effects. Enzyme Activators / pharmacology. Humans. Magnesium / pharmacology. Manganese / pharmacology. Mice. Mice, Inbred C57BL. Mutation

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20673215.001).
  • [ISSN] 1608-3040
  • [Journal-full-title] Biochemistry. Biokhimii︠a︡
  • [ISO-abbreviation] Biochemistry Mosc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Enzyme Activators; 42Z2K6ZL8P / Manganese; EC 2.7.7.- / DNA polymerase iota; EC 2.7.7.7 / DNA-Directed DNA Polymerase; I38ZP9992A / Magnesium
  •  go-up   go-down


20. Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ, Johnson KR: Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol; 2008 Mar 24;180(6):1277-89
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1.
  • Tumor cells undergo epithelial-to-mesenchymal transition (EMT) to convert from a benign to a malignant phenotype.
  • We have shown that human pancreatic cancer cells respond to collagen by up-regulating N-cadherin, which promotes tumor growth, invasion, and metastasis.
  • Initial characterization showed that knocking down c-Jun NH2-terminal kinase prevented N-cadherin up-regulation and limited tumor growth and invasion in a mouse model for pancreatic cancer.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2002 Feb 15;295(5558):1285-8 [11847339.001]
  • [Cites] Nat Cell Biol. 2002 Apr;4(4):E83-90 [11944041.001]
  • [Cites] Am J Pathol. 2002 Jun;160(6):2001-8 [12057905.001]
  • [Cites] BMC Cell Biol. 2002 Jul 15;3:18 [12119061.001]
  • [Cites] Nat Rev Cancer. 2002 Jun;2(6):442-54 [12189386.001]
  • [Cites] J Biol Chem. 2002 Sep 6;277(36):32970-7 [12087088.001]
  • [Cites] Cell. 2002 Sep 20;110(6):673-87 [12297042.001]
  • [Cites] J Cell Biol. 2002 Nov 11;159(3):465-76 [12427869.001]
  • [Cites] Cancer Res. 2002 Nov 15;62(22):6688-97 [12438268.001]
  • [Cites] Dev Cell. 2003 Jan;4(1):11-8 [12530959.001]
  • [Cites] Cell. 2003 Mar 7;112(5):673-84 [12628187.001]
  • [Cites] J Biol Chem. 2003 May 9;278(19):17269-76 [12604612.001]
  • [Cites] Cell. 2003 Jun 13;113(6):685-700 [12809600.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Aug;4(8):657-65 [12923528.001]
  • [Cites] J Biol Chem. 2003 Nov 14;278(46):45801-10 [12954618.001]
  • [Cites] Curr Opin Cell Biol. 2003 Dec;15(6):740-6 [14644200.001]
  • [Cites] J Am Soc Nephrol. 2004 Jan;15(1):1-12 [14694152.001]
  • [Cites] Front Biosci. 2004 May 1;9:1254-66 [14977542.001]
  • [Cites] Trends Biochem Sci. 2004 May;29(5):265-73 [15130563.001]
  • [Cites] Cancer Res. 1998 Jan 1;58(1):14-9 [9426049.001]
  • [Cites] J Biol Chem. 1998 Jan 16;273(3):1281-4 [9430657.001]
  • [Cites] Trends Cell Biol. 1998 Apr;8(4):151-7 [9695829.001]
  • [Cites] J Cell Biol. 1998 Nov 30;143(5):1385-98 [9832565.001]
  • [Cites] Biochim Biophys Acta. 2004 Jul 5;1692(2-3):63-76 [15246680.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31041-9 [15143071.001]
  • [Cites] J Cell Biol. 2004 Jul 19;166(2):283-95 [15263022.001]
  • [Cites] J Biol Chem. 2004 Aug 6;279(32):33315-22 [15166227.001]
  • [Cites] Oncogene. 2004 Aug 5;23(35):5978-85 [15184866.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35127-32 [15166221.001]
  • [Cites] J Cell Sci. 2004 Sep 15;117(Pt 20):4691-703 [15331629.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26 [15459662.001]
  • [Cites] J Cell Biol. 2004 Oct 11;167(1):111-22 [15479739.001]
  • [Cites] Respir Res. 2006;7:114 [16948840.001]
  • [Cites] Exp Eye Res. 2006 Dec;83(6):1309-16 [16769055.001]
  • [Cites] Microbiol Mol Biol Rev. 2006 Dec;70(4):1061-95 [17158707.001]
  • [Cites] Cancer Res. 2006 Dec 15;66(24):11745-53 [17178870.001]
  • [Cites] J Cell Sci. 2007 Jan 1;120(Pt 1):17-22 [17182900.001]
  • [Cites] J Am Soc Nephrol. 2007 Mar;18(3):846-59 [17267741.001]
  • [Cites] Cell Signal. 2007 May;19(5):923-31 [17197157.001]
  • [Cites] Cancer Res. 2007 Apr 1;67(7):3106-16 [17409417.001]
  • [Cites] Int J Cancer. 2008 Jan 1;122(1):71-7 [17721921.001]
  • [Cites] Am J Respir Cell Mol Biol. 2008 Jan;38(1):95-104 [17673689.001]
  • [Cites] J Cell Biol. 1999 Nov 1;147(3):631-44 [10545506.001]
  • [Cites] J Biol Chem. 2000 Feb 25;275(8):5779-84 [10681566.001]
  • [Cites] J Cell Biol. 2000 Feb 21;148(4):779-90 [10684258.001]
  • [Cites] J Cell Biol. 2000 Mar 20;148(6):1151-8 [10725328.001]
  • [Cites] Cancer Res. 2000 Jul 1;60(13):3650-4 [10910081.001]
  • [Cites] Curr Biol. 2000 Aug 24;10(16):974-8 [10985384.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3508-17 [11309315.001]
  • [Cites] Am J Pathol. 2001 Oct;159(4):1313-21 [11583959.001]
  • [Cites] Bioessays. 2001 Oct;23(10):912-23 [11598958.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5192-6 [1594631.001]
  • [Cites] J Cell Biol. 1993 May;121(3):673-8 [8387531.001]
  • [Cites] Exp Cell Res. 1993 Aug;207(2):252-60 [8344378.001]
  • [Cites] Exp Cell Res. 1994 Apr;211(2):175-82 [8143763.001]
  • [Cites] Pancreas. 1995 Nov;11(4):357-64 [8532652.001]
  • [Cites] J Biol Chem. 1996 Mar 22;271(12):6794-800 [8636102.001]
  • [Cites] J Cell Biol. 1996 Dec;135(6 Pt 1):1643-54 [8978829.001]
  • [Cites] Cancer Res. 1999 Feb 15;59(4):947-52 [10029089.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2805-10 [10077592.001]
  • [Cites] J Biol Chem. 1999 May 21;274(21):14893-901 [10329689.001]
  • [Cites] J Biol Chem. 1999 Oct 8;274(41):28966-71 [10506143.001]
  • [Cites] Clin Cancer Res. 2004 Nov 1;10(21):7427-37 [15534120.001]
  • [Cites] J Cell Sci. 2005 Mar 1;118(Pt 5):873-87 [15713751.001]
  • [Cites] Cell Oncol. 2005;27(1):3-13 [15750203.001]
  • [Cites] Science. 2005 Mar 11;307(5715):1603-9 [15761148.001]
  • [Cites] Science. 2005 Mar 11;307(5715):1621-5 [15761153.001]
  • [Cites] Curr Opin Cell Biol. 2005 Apr;17(2):123-8 [15780587.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):907-21 [15825074.001]
  • [Cites] Nature. 2005 Jul 7;436(7047):123-7 [16001073.001]
  • [Cites] J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84 [16105881.001]
  • [Cites] Oncogene. 2005 Aug 29;24(37):5764-74 [16123809.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):898-906 [16424023.001]
  • [Cites] Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42 [16493418.001]
  • [Cites] Oncogene. 2006 Mar 2;25(9):1378-90 [16247454.001]
  • [Cites] J Cell Biol. 2006 Mar 27;172(7):973-81 [16567498.001]
  • [Cites] Cancer Res. 2006 May 1;66(9):4662-71 [16651417.001]
  • [Cites] Br J Cancer. 2006 May 8;94(9):1311-9 [16622460.001]
  • [Cites] Cell Signal. 2006 Aug;18(8):1108-16 [16626936.001]
  • [Cites] Trends Cell Biol. 2006 May;16(5):257-63 [16581250.001]
  • [Cites] Mol Biol Cell. 2006 Jul;17(7):2963-75 [16624865.001]
  • [Cites] Hepatogastroenterology. 2001 Sep-Oct;48(41):1321-7 [11677955.001]
  • [Cites] Cancer Lett. 2002 Feb 25;176(2):123-8 [11804738.001]
  • (PMID = 18362184.001).
  • [ISSN] 1540-8140
  • [Journal-full-title] The Journal of cell biology
  • [ISO-abbreviation] J. Cell Biol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01-GM51188; United States / NIDCR NIH HHS / DE / R01-DE12308; United States / NIDCR NIH HHS / DE / R01 DE012308; United States / NCI NIH HHS / CA / P30 CA036727; United States / NCI NIH HHS / CA / P30 CA36727; United States / NIGMS NIH HHS / GM / R01 GM051188
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BCAR1 protein, human; 0 / Cadherins; 0 / Collagen Type I; 0 / Crk-Associated Substrate Protein; 0 / Integrin alpha2beta1; 0 / Receptors, Mitogen; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / discoidin receptor; EC 2.7.10.2 / Focal Adhesion Kinase 2; EC 2.7.10.2 / Focal Adhesion Protein-Tyrosine Kinases; EC 3.6.5.2 / rap1 GTP-Binding Proteins
  • [Other-IDs] NLM/ PMC2290851
  •  go-up   go-down


21. Tsuchiya T, Nakahama K, Asakawa Y, Maemura T, Tanaka M, Takeda S, Morita M, Morita I: The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Gynecol Endocrinol; 2009 Feb;25(2):104-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Microvessel density (MVD) was evaluated by the total microvessel length in high-power field of tumor tissue preparations.
  • RESULTS: MVD correlated with tumor malignancy.
  • The VEGF expression levels in some malignant tumors (VEGF-L) were as low as that in benign tumors.
  • The PEDF expression levels in VEGF-L malignant tumors were significantly lower than those in benign tumors.
  • On the other hand, the PEDF expression levels in VEGF-H malignant tumor tissues were not significantly different from those in benign tumors.
  • CONCLUSION: The reduction in PEDF expression levels may be, in part, responsible for tumor malignancy in VEGF-L ovarian tumors.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / physiopathology. Eye Proteins / genetics. Nerve Growth Factors / genetics. Ovarian Neoplasms / pathology. Ovarian Neoplasms / physiopathology. Serpins / genetics. Vascular Endothelial Growth Factor A / genetics
  • [MeSH-minor] Adenocarcinoma, Clear Cell / blood supply. Adenocarcinoma, Clear Cell / pathology. Adenocarcinoma, Clear Cell / physiopathology. Biomarkers, Tumor / metabolism. Blotting, Western. Carcinoma, Endometrioid / blood supply. Carcinoma, Endometrioid / pathology. Carcinoma, Endometrioid / physiopathology. Female. Gene Expression Regulation, Neoplastic. Humans. Microcirculation / physiology. Neoplasms / blood supply. Neoplasms / pathology. Neoplasms / physiopathology. Neovascularization, Pathologic / metabolism. Neovascularization, Pathologic / pathology. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19253105.001).
  • [ISSN] 1473-0766
  • [Journal-full-title] Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • [ISO-abbreviation] Gynecol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Eye Proteins; 0 / Nerve Growth Factors; 0 / Serpins; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A; 0 / pigment epithelium-derived factor
  •  go-up   go-down


22. Karl A, Stepp H, Willmann E, Buchner A, Hocaoglu Y, Stief C, Tritschler S: Optical coherence tomography for bladder cancer -- ready as a surrogate for optical biopsy? Results of a prospective mono-centre study. Eur J Med Res; 2010 Mar 30;15(3):131-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: New modalities like Optical Coherence Tomography (OCT) allow non-invasive examination of the internal structure of biological tissue in vivo.
  • Of all analyzed lesions 88 were benign (inflammation, edema, hyperplasia etc.) and 14 were malignant (CIS, Ta, T1, T2) as shown by final histo?pathology.
  • Furthermore all invasive tumors were staged correctly by OCT regarding tumor growth beyond the lamina propria.
  • Sensitivity of OCT for detecting the presence of a malignant lesion was 100% and sensitivity for detection of tumor growth beyond the lamina propria was 100% as well.
  • CONCLUSION: As a minimally invasive technique, OCT proved to have extremely high sensitivity for detection of malignant lesions as well as estimation of whether a tumor has invaded beyond the lamina propria.
  • [MeSH-major] Cystoscopy. Tomography, Optical Coherence. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Prognosis. Prospective Studies. Sensitivity and Specificity. Young Adult

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2000 Jun;163(6):1693-6 [10799162.001]
  • [Cites] Skin Res Technol. 2001 Feb;7(1):1-9 [11301634.001]
  • [Cites] Med Phys. 2001 Dec;28(12):2432-40 [11797946.001]
  • [Cites] J Urol. 2002 Mar;167(3):1492-6 [11832776.001]
  • [Cites] J Endourol. 2005 Jun;19(5):570-4 [15989448.001]
  • [Cites] J Endourol. 2009 Feb;23(2):197-201 [19196063.001]
  • [Cites] J Urol. 2005 Dec;174(6):2376-81 [16280851.001]
  • [Cites] Prog Retin Eye Res. 2006 May;25(3):325-53 [16716639.001]
  • [Cites] J Endourol. 2007 Aug;21(8):814-8 [17867934.001]
  • [Cites] Urology. 2008 Jul;72(1):198-204 [18280549.001]
  • [Cites] J Endourol. 2008 Nov;22(11):2429-32 [19046083.001]
  • [Cites] J Dermatol Sci. 2005 Nov;40(2):85-94 [16139481.001]
  • (PMID = 20452899.001).
  • [ISSN] 0949-2321
  • [Journal-full-title] European journal of medical research
  • [ISO-abbreviation] Eur. J. Med. Res.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC3352220
  •  go-up   go-down


23. Brovkina AF, Tadzhieva ZA, Sherstnev VV: [Clinical and epidemiological study of lacrimal neoplasms]. Vestn Oftalmol; 2009 May-Jun;125(3):3-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical and epidemiological study of lacrimal neoplasms].
  • A cross-sectional mass epidemiological survey of 18,320 urban and rural citizens of the Republic of Tadjikistan revealed 31 patients with orbital tumors, of which lacrimal neoplasms were determined in 4 (0.022% in the general population and 12.9% of the identified orbital tumors).
  • According to the referral data, the prevalence of lacrimal neoplasms was 1.03% of all the tumors of the organ of vision and 5.26% of the orbital neoplasms.
  • Epithelial tumors were more common (52%), their malignant forms dominated over benign ones (55.7% versus 44.3%).
  • Lymphoid tissue tumors (13.6%), cystoid masses (8.6%), and neoplasms of unclear genesis (1.4%) were noticeably less prevalent.
  • With the higher grade of anaplasia, the likelihood of a recurrence of a tumor and the rate of its growth increased (r = +0.83).
  • [MeSH-major] Eye Neoplasms / epidemiology. Lacrimal Apparatus
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Morbidity. Population Surveillance. Retrospective Studies. Tajikistan / epidemiology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19566038.001).
  • [ISSN] 0042-465X
  • [Journal-full-title] Vestnik oftalmologii
  • [ISO-abbreviation] Vestn Oftalmol
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


24. Milman T, Finger PT, Iacob C, Garcia JP Jr, Della Rocca DA, McCormick SA: Fibrous histiocytoma. Ophthalmology; 2007 Dec;114(12):2369-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Corneal Diseases / pathology. Eye Neoplasms / pathology. Histiocytoma, Benign Fibrous / pathology. Limbus Corneae / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Female. Glucocorticoids / therapeutic use. Humans. Immunoenzyme Techniques. Keratoplasty, Penetrating. Lupus Erythematosus, Systemic / complications. Lupus Erythematosus, Systemic / drug therapy. Middle Aged. Orbit Evisceration. Prednisone / therapeutic use

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18054660.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Glucocorticoids; VB0R961HZT / Prednisone
  •  go-up   go-down


25. Evans PM, Lynch GL, Dubielzig RR: Anterior uveal spindle cell tumor in a cat. Vet Ophthalmol; 2010 Nov;13(6):387-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anterior uveal spindle cell tumor in a cat.
  • PURPOSE: To describe a case of anterior uveal spindle cell tumor in a cat with features similar to spindle cell tumor of blue eyed dogs.
  • A diagnosis of a benign epithelial tumor was suggested by a FNA of the mass.
  • CONCLUSIONS: Based on its histopathologic characteristics, this iris tumor was diagnosed as a Schwann cell variant of a peripheral nerve sheath tumor (PNST) closely resembling the spindle cell tumor of blue-eyed dogs.
  • The presence of Antoni type A and type B tissue patterns along with immunohistochemical staining may facilitate a diagnosis of PNST and rule out malignant melanoma.
  • [MeSH-major] Cat Diseases / pathology. Uveal Neoplasms / veterinary

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 American College of Veterinary Ophthalmologists.
  • (PMID = 21182724.001).
  • [ISSN] 1463-5224
  • [Journal-full-title] Veterinary ophthalmology
  • [ISO-abbreviation] Vet Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


26. Singh R, Chattopadhyay A, Agarwal A, Bhattacharya SK, Bhattacharya AK: Oxidants and ocular tumors. Ann Ophthalmol (Skokie); 2006;38(3):231-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oxidants and ocular tumors.
  • Serum superoxide dismutase and catalase assays were performed using spectrophotometry in 60 adults and children with benign or malignant tumors and in controls.
  • These enzymes may be of value in the early diagnosis of malignant intraocular tumor, especially retinoblastoma.
  • [MeSH-major] Eye Neoplasms / etiology. Oxidants / metabolism. Retinoblastoma / etiology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17416959.001).
  • [ISSN] 1558-9951
  • [Journal-full-title] Annals of ophthalmology (Skokie, Ill.)
  • [ISO-abbreviation] Ann Ophthalmol (Skokie)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oxidants; EC 1.11.1.6 / Catalase; EC 1.15.1.1 / Superoxide Dismutase
  •  go-up   go-down


27. Dimaras H, Gallie BL: The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development. Int J Cancer; 2008 May 01;122(9):2023-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development.
  • The transition from the benign retinal tumor retinoma to its malignant counterpart retinoblastoma is accompanied by the loss of expression of the p75(NTR) neurotrophin receptor.
  • We sought to determine the functional effect on tumor development of absence of p75(NTR) from the onset of TAg-RB tumor initiation.
  • The average tumor area per eye as a percentage of retinal area was measured.
  • TAg-RB/E3KO (TAg-RB(E3KO)) and heterozygous mice showed no significant difference in tumor area compared to the TAg-RB control mice at any time point studied.
  • However, TAg-RB/E4KO (TAg-RB(E4KO)) and heterozygous mice displayed a significantly larger tumor area than the TAg-RB control mice.
  • [MeSH-major] Receptor, Nerve Growth Factor / metabolism. Retinal Neoplasms / metabolism. Retinoblastoma / metabolism. Tumor Suppressor Proteins / metabolism
  • [MeSH-minor] Adenoviridae. Animals. Apoptosis. Caspase 3 / metabolism. Cell Line, Tumor. Cell Transformation, Neoplastic. Enzyme Activation. Fluorescent Antibody Technique. Gene Expression Regulation, Enzymologic. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Mice. Neoplasms, Experimental / metabolism

  • Genetic Alliance. consumer health - Retinoblastoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18196575.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA118830
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptor, Nerve Growth Factor; 0 / Tumor Suppressor Proteins; EC 3.4.22.- / Caspase 3
  •  go-up   go-down


28. Yao J, Chen RJ, Sun XH: [Analysis of the relationship between pathology and recurrence of primary lacrimal epithelial tumors]. Zhonghua Yan Ke Za Zhi; 2006 Jul;42(7):590-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: 128 cases of primary lacrimal epithelial tumors including benign mixed tumor (74 cases, 57.8%), adenoid cystic carcinoma (22 cases, 17.2%) and malignant mixed tumor (18 cases, 14.1%) were subjected in the study.
  • RESULTS: The recurrent rate of benign mixed tumor, adenoid cystic carcinoma and malignant mixed tumor was 23.0%, 18.2% and 27.8%, respectively.
  • The recurrence of benign mixed tumor was statistically related to pathological classification and encapsulates.
  • The pathological features were decisive in diagnosis, selection of treatment and the time of follow-up.
  • [MeSH-major] Carcinoma, Adenoid Cystic / pathology. Eye Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology. Neoplasms, Complex and Mixed / pathology
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17081415.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


29. Gulias-Cañizo R, Aranda-Rábago J, Rodríguez-Reyes AA: [Seborrheic keratosis of conjunctiva: a case report]. Arch Soc Esp Oftalmol; 2006 Apr;81(4):217-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Queratosis seborreica de la conjuntiva: informe de un caso.
  • A 37-year-old man presented with a pigmented mass involving the conjunctiva of his right eye.
  • Clinically, a diagnosis of malignant melanoma was made and a wide excision of the tumor was performed.
  • The histopathologic diagnosis was seborrheic keratosis.
  • DISCUSSION: Seborrheic keratosis is a benign lesion which occurs on the eyelids and face of middle-aged and elderly individuals.
  • Seborrheic keratosis should be considered in the differential diagnosis of conjunctival pigmented lesions.

  • Genetic Alliance. consumer health - Keratosis, seborrheic.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16688646.001).
  • [ISSN] 0365-6691
  • [Journal-full-title] Archivos de la Sociedad Española de Oftalmología
  • [ISO-abbreviation] Arch Soc Esp Oftalmol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


30. Ayberk G, Ozveren MF, Uzum N, Tosun O, Akcay EK: Cellular schwannoma of the greater superficial petrosal nerve presenting with abducens nerve palsy and xerophthalmia: case report. Neurosurgery; 2008 Oct;63(4):E813-4; discussion E814
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schirmer's test revealed decreased tear secretion in the right eye.
  • It was thought that the schwannoma in our patient originated from the greater superficial petrosal nerve, based on the location of the tumor in addition to the absence of partial Horner's syndrome and a persistent decrease in tear secretion.
  • INTERVENTION: The tumor was exposed with the use of a right subtemporal extradural approach and removed entirely.
  • Pathological evaluation of the tumor revealed a CS.
  • No adjuvant treatment was applied because of the tumor's benign character.
  • The greater superficial petrosal nerve schwannoma should be considered in the differential diagnosis of the abducens nerve palsy and petrous apex mass.

  • Genetic Alliance. consumer health - Schwannoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981849.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Soong T, Soong V, Salvi SM, Raynor M, Mudhar H, Goel S, Edwards M: Primary corneal myxoma. Cornea; 2008 Dec;27(10):1186-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These include an inferonasal location between the corneal epithelium and Bowman layer and with no relationship to the corneal stroma, rapid tumor growth over a 3-month period, and no previous ocular trauma or conjunctival pathology.
  • The histology of this lesion has an important part to play in the management of this condition as it determines the cellular origin, establishes a benign or malignant state, and helps with treatment and prognosis.
  • [MeSH-major] Corneal Diseases / pathology. Corneal Diseases / surgery. Eye Neoplasms / pathology. Eye Neoplasms / surgery. Myxoma / pathology. Myxoma / surgery

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19034139.001).
  • [ISSN] 1536-4798
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Zhang CF, Dong FT, Chen YX, Du H, Han BL: [Clinical manifestation and follow-up of melanocytoma of the optic disc]. Zhonghua Yan Ke Za Zhi; 2009 Apr;45(4):296-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All cases were unilateral involved, 5 cases were right eye, 5 cases were left eye.
  • The distribution of the visual acuity was follows: light perception in 2 eyes, 20/200 in one eye, 20/20 or above in 7 eyes.
  • The tumor mass at the optic disc with extensive serous detachment of retina was detected on B-scan in one eye.
  • The benign melanocytoma was diagnosed by vitreous fine needle biopsy for this eye.
  • In other case, the tumor was found to be enlarged, visual field defect deteriorated, pigment granules appeared in the vitreous adjacent to the tumor during on year follow-up period.
  • On the patient request, enucleation was performed to rule out the malignancy of the tumor.
  • Pathologic study showed that the tumor cells were active, but benign state.
  • The tumor size and visual acuity in other eight eyes remained stable in the follow-up period with one to 18 years (mean 3.5 years).
  • On FFA and ICGA, bilateral choroidal nevi were found in one eye.
  • CONCLUSIONS: Melanocytoma of the optic disc is a benign tumor that rarely causes visual impairment.
  • However, visual acuity may be impaired due to enlargement of the tumor or necrosis in tumor.
  • [MeSH-major] Melanoma / diagnosis. Optic Disk / pathology. Optic Nerve Neoplasms / diagnosis
  • [MeSH-minor] Adult. Choroid Neoplasms / diagnosis. Female. Follow-Up Studies. Humans. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19575959.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


33. Fichter N, Schittkowski M, Guthoff RF: [Diseases of the lacrimal gland]. Ophthalmologe; 2005 Apr;102(4):399-423; quiz 424-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Experience with the differential diagnosis of lacrimal gland illnesses is limited in daily practice due to their rarity.
  • It is therefore of particular importance to have guidelines for the practitioner by which he can decide on the application of conservative or surgical therapy, and whether it is necessary to take a biopsy to clarify the diagnosis.
  • There is a wide spectrum of possible illnesses which include systemic diseases, inflammatory disorders, neoplastic, benign and malignant tumors.
  • When a pleomorphic adenoma cannot be excluded, biopsy is contraindicated and complete tumor excision with its capsule is necessary to prevent the possibility of malignant transformation and a negative effect on long-term prognosis.
  • In this overview, special interest is placed on the typical clinical aspects and imaging features of lesions of the lacrimal gland fossa, their differential diagnosis and management.
  • [MeSH-major] Adenoma, Pleomorphic / diagnosis. Eye Neoplasms / diagnosis. Lacrimal Apparatus Diseases / diagnosis
  • [MeSH-minor] Biopsy. Cell Transformation, Neoplastic / pathology. Diagnosis, Differential. Humans. Lacrimal Apparatus / pathology. Practice Guidelines as Topic

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surv Ophthalmol. 1996 Jul-Aug;41(1):66-78 [8827931.001]
  • [Cites] Klin Monbl Augenheilkd. 2002 Jun;219(6):458-61 [12136444.001]
  • [Cites] Eye (Lond). 2004 Jan;18(1):77-9 [14707973.001]
  • [Cites] Am J Ophthalmol. 1985 May 15;99(5):547-51 [4003490.001]
  • [Cites] Front Radiat Ther Oncol. 1997;30:165-71 [9205898.001]
  • [Cites] Arch Ophthalmol. 1998 May;116(5):613-6 [9596497.001]
  • [Cites] Br J Ophthalmol. 2002 Feb;86(2):249-50 [11815361.001]
  • [Cites] Arch Ophthalmol. 1986 Mar;104(3):380-4 [3954638.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 Mar;17 (2):131-3 [11281587.001]
  • [Cites] Arch Ophthalmol. 1980 Sep;98(9):1621-2 [7425926.001]
  • [Cites] Surv Ophthalmol. 2003 Jan-Feb;48(1):39-57 [12559326.001]
  • [Cites] Br J Ophthalmol. 1980 Jul;64(7):515-7 [7426565.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 Sep;17 (5):346-54 [11642491.001]
  • [Cites] Ophthalmologe. 2004 Feb;101(2):197-215; quiz 216-7 [15046030.001]
  • [Cites] Arch Ophthalmol. 1998 Mar;116(3):315-21 [9514484.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 Mar;17 (2):137-9 [11281589.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2003 Nov;241(11):907-13 [14579116.001]
  • [Cites] Ophthal Plast Reconstr Surg. 1999 May;15(3):171-9 [10355835.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):172-6 [12909230.001]
  • [Cites] Ophthalmology. 1998 Aug;105(8):1430-41 [9709754.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234(8):504-9 [8858356.001]
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):219-39, xii [10026740.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2004 Feb;242(2):130-145 [14685876.001]
  • [Cites] Arch Ophthalmol. 2004 May;122(5):778-80 [15136329.001]
  • [Cites] Ophthal Plast Reconstr Surg. 1999 Mar;15(2):129-33 [10189642.001]
  • [Cites] Ophthalmology. 1994 Mar;101(3):570-84 [8127579.001]
  • [Cites] Eur J Ophthalmol. 2002 May-Jun;12(3):241-3 [12113573.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 May;17(3):191-4 [11388385.001]
  • [Cites] Br J Ophthalmol. 1992 Jul;76(7):401-7 [1320924.001]
  • [Cites] Acta Ophthalmol (Copenh). 1994 Aug;72(4):520-3 [7825423.001]
  • [Cites] Arch Ophthalmol. 2003 Mar;121(3):412-3 [12617717.001]
  • [Cites] Br J Ophthalmol. 1991 Aug;75(8):491-2 [1873270.001]
  • [Cites] Ophthalmology. 1996 Oct;103(10):1613-8 [8874434.001]
  • [Cites] Ophthalmology. 1995 Dec;102(12):1994-2006 [9098307.001]
  • [Cites] Ophthalmologica. 1985;190(4):230-42 [4011135.001]
  • [Cites] Br J Ophthalmol. 1992 Jul;76(7):395-400 [1320923.001]
  • [Cites] Radiologe. 2001 Jun;41(6):520-7; quiz 528 [11458788.001]
  • [Cites] Br J Ophthalmol. 2001 Jan;85(1):63-9 [11133714.001]
  • [Cites] Arch Ophthalmol. 2003 Apr;121(4):491-9 [12695246.001]
  • [Cites] Ann Oncol. 1998 Jul;9(7):779-81 [9739446.001]
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):151-68, xi [10026735.001]
  • [Cites] Curr Opin Ophthalmol. 2002 Dec;13(6):347-51 [12441835.001]
  • (PMID = 15782290.001).
  • [ISSN] 0941-293X
  • [Journal-full-title] Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
  • [ISO-abbreviation] Ophthalmologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


34. Al-Khiary H, Ayoubi A, Elkhamary SM: Primary orbital ganglioneuroma in a 2-year-old healthy boy. Saudi J Ophthalmol; 2010 Jul;24(3):101-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He underwent orbital exploration via anterior orbitotomy incision and debulking of the tumor was done.
  • The histopathological examination confirmed the diagnosis of orbital ganglioneuroma.
  • Ganglioneuroma is an unusual benign tumor of neuroplastic origin with extremely rare orbital involvement with only one prior reported case in a youth.
  • The tumor is slow growing and non-metastasizing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23960884.001).
  • [ISSN] 1319-4534
  • [Journal-full-title] Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
  • [ISO-abbreviation] Saudi J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  • [Other-IDs] NLM/ PMC3729488
  • [Keywords] NOTNLM ; Ganglioneuroma / Neuroblastoma / Pediatric / Unilateral proptosis
  •  go-up   go-down


35. Finn M, Krohne S, Stiles J: Ocular melanocytic neoplasia. Compend Contin Educ Vet; 2008 Jan;30(1):19-25; quiz 26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ocular melanocytic neoplasia.
  • Tumors of melanocytic origin in ocular tissues are relatively uncommon in dogs and cats, and although many are benign, some have a high potential for metastasis.
  • In addition, even small ocular masses can be significant due to their potential vision-threatening sequelae.
  • While several similarities exist among these tumors, the prognosis and recommended treatment options vary based on the species affected as well as the location, extent, and histologic characteristics of the tumor.
  • [MeSH-major] Cat Diseases / diagnosis. Dog Diseases / diagnosis. Eye Neoplasms / veterinary. Melanoma / veterinary

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18278744.001).
  • [ISSN] 1940-8315
  • [Journal-full-title] Compendium (Yardley, PA)
  • [ISO-abbreviation] Compend Contin Educ Vet
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


36. Burduk PK, Seredyka-Burduk M, Olejarz E: [Giant tumor of the orbit--a case of hidradenoma]. Otolaryngol Pol; 2007;61(6):1017-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant tumor of the orbit--a case of hidradenoma].
  • The most common symptoms are ophthalmology dysfunction as: exophthalmus, eye movement dysfunction and visual loss.
  • More often a benign lesions is found than malignant.
  • We present a case of 62 years old man with large expansion of benign tumor of the orbit with exophthalmus, eye movement disability and complete blindness.
  • Histopathology described a very rare tumor of the orbit-hidradenoma.
  • [MeSH-major] Adenoma, Sweat Gland / diagnosis. Orbital Neoplasms / diagnosis. Sweat Gland Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18546956.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


37. Kim HJ, Shields CL, Eagle RC Jr, Shields JA: Fibrous histiocytoma of the conjunctiva. Am J Ophthalmol; 2006 Dec;142(6):1036-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor was present for a mean of three months (median, five months; range, one to 12 months) and was unilateral (one right eye, five left eyes).
  • In all cases, the tumor was a tan, dome-shaped limbal mass in the conjunctival stroma with visible intrinsic vessels.
  • The mean tumor basal dimension was 7 mm (median, 5 mm; range, 4 to 11 mm).
  • Surgical resection was performed in all cases, and histopathologic study demonstrated benign FH in four cases and malignant FH in two cases.
  • Those cases with benign FH showed no recurrence over nine months (median, eight months; range, three to 18 months).
  • CONCLUSION: FH is a rare conjunctival tumor that can show benign or malignant features.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Histiocytoma, Benign Fibrous / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Child. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Retrospective Studies

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17157587.001).
  • [ISSN] 0002-9394
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


38. Rizvi SA, Gupta Y, Gupta M: Surgical treatment and histopathological analysis of proptosis. Nepal J Ophthalmol; 2010 Jan-Jun;2(1):31-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • According to location and type of tumour, different surgical options like anterior orbitotomy, lateral orbitotomy and medial orbitotomy were considered.
  • The most common benign adult tumor found in our study was pleomorphic adenoma of the lacrimal gland {3 (20%)}.
  • Early diagnosis and timely surgical intervention provide good functional and cosmetic results.
  • [MeSH-major] Exophthalmos / surgery. Eye Neoplasms / pathology. Ophthalmologic Surgical Procedures / methods. Orbital Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biopsy. Child. Child, Preschool. Diagnosis, Differential. Humans. Infant. Infant, Newborn. Middle Aged. Retrospective Studies. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21141324.001).
  • [ISSN] 2072-6805
  • [Journal-full-title] Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
  • [ISO-abbreviation] Nepal J Ophthalmol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


39. McKenna M, Brodsky L: Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol; 2005 May;69(5):597-605
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Recurrent respiratory papillomatosis (RRP) is a benign infectious disease which is caused by the human papilloma virus (HPV).
  • The clinical course of the papillomatosis and the diagnosis and treatment of reflux are compared over time.
  • Prompt diagnosis and effective treatment of EERD should be considered in all patients with difficult to control RRP or with clinical presentation or endoscopic signs of EERD.
  • [MeSH-major] Gastroesophageal Reflux / complications. Gastroesophageal Reflux / diagnosis. Laryngeal Neoplasms / complications. Neoplasm Recurrence, Local / complications. Papilloma / complications
  • [MeSH-minor] Airway Obstruction / etiology. Airway Obstruction / therapy. Child. Child, Preschool. Humans. Male. Papillomaviridae. Papillomavirus Infections / complications. Papillomavirus Infections / therapy. Severity of Illness Index. Tumor Virus Infections / complications. Tumor Virus Infections / therapy

  • MedlinePlus Health Information. consumer health - GERD.
  • MedlinePlus Health Information. consumer health - Reflux in Children.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Pediatr Otorhinolaryngol. 2006 Apr;70(4):757-8; author reply 759 [16242786.001]
  • (PMID = 15850681.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


40. Trisvetova EL: [Clinical diagnostics of papillary fibroelastoma]. Klin Med (Mosk); 2007;85(12):7-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Papillary fibroelastoma (PFE) is a benign heart tumor, the diagnosis of which is difficult.
  • Clinical manifestations of PFE are non-specific and scarce, and for this reason the tumor is often revealed during a heart surgery of an autopsy.
  • The histogenesis of the tumor is unclear; there are several theories of PFE origin (hemodynamic effects on the myocardium, viral theory, iatrogenic theory etc.
  • ) Macroscopically the tumor is small size, villous, whitish-grey, consists of a pedicle and villi of gely-like soft or dense-elastic consistence.
  • The mobility of the tumor and the fragmentation of its tissue lead to its main complications such as obstruction of cardiac cameras (in-flow and out-flow disorders) and embolic syndrome in various basins (the brain, coronary arteries, the eye, the kidneys, and the lungs).
  • The diagnosis of PFE is made using EchoCG, preferably transesophageal one.
  • Treatment of PFE is surgical and consists of tumor or cusp removal.
  • PFE should be differentiated from other benign and malignant heart tumors, infective endocarditis, heart echinococcosis, coronary artery disease, and cerebrovascular diseases.
  • [MeSH-major] Cardiac Surgical Procedures / methods. Fibroma. Heart Neoplasms. Ventricular Function / physiology
  • [MeSH-minor] Diagnosis, Differential. Echocardiography, Transesophageal. Humans. Papillary Muscles / pathology. Papillary Muscles / ultrasonography. Prognosis

  • MedlinePlus Health Information. consumer health - Heart Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18318158.001).
  • [ISSN] 0023-2149
  • [Journal-full-title] Klinicheskaia meditsina
  • [ISO-abbreviation] Klin Med (Mosk)
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Russia (Federation)
  • [Number-of-references] 49
  •  go-up   go-down


41. Hazzaa SM, Elashry OM, Afifi IK: Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol Oncol Res; 2010 Mar;16(1):101-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Blood and urine samples were used from 68 patients with TCC of the bladder and from 61 patients with benign urological diseases.
  • Quantitation of clusterin mRNA was carried out in 68 bladder tumor specimens from radical cystectomy or transurethral resection and 26 normal bladder specimens from BPH patients by using RT-PCR method.
  • Sensitivity and specificity of serum and urine clusterin as a tumor marker for TCC of the bladder was found to be 80%, 91%, 87.1% and 96.7% respectively.
  • Overexpression of clusterin mRNA was significantly associated with tumor recurrence and overall survival (p < 0.001).
  • [MeSH-major] Biomarkers, Tumor / analysis. Carcinoma, Transitional Cell / diagnosis. Clusterin / biosynthesis. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Adult. Enzyme-Linked Immunosorbent Assay. Female. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Transitional cell carcinoma.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2003 Mar 28;278(13):11590-600 [12551933.001]
  • [Cites] Pancreas. 2002 Oct;25(3):234-8 [12370533.001]
  • [Cites] Trends Biochem Sci. 1992 Apr;17(4):154-9 [1585460.001]
  • [Cites] Am J Surg Pathol. 1998 Dec;22(12):1435-48 [9850170.001]
  • [Cites] J Urol. 2001 May;165(5):1481-7 [11342901.001]
  • [Cites] World J Urol. 2008 Feb;26(1):1-3 [18060549.001]
  • [Cites] Mol Cancer Ther. 2004 Mar;3(3):223-32 [15026542.001]
  • [Cites] Cell Death Differ. 2006 Jan;13(1):12-9 [16179938.001]
  • [Cites] J Biol Chem. 1983 Jun 25;258(12):7714-20 [6863260.001]
  • [Cites] Urology. 2006 Jan;67(1):105-9 [16413343.001]
  • [Cites] Diagn Cytopathol. 1995 Oct;13(3):214-23; discussion 224 [8575280.001]
  • [Cites] Clin Cancer Res. 1997 Oct;3(10):1707-11 [9815554.001]
  • [Cites] Int J Biochem Cell Biol. 2002 May;34(5):427-31 [11906815.001]
  • [Cites] Prostate. 2004 Dec 1;61(4):318-23 [15389725.001]
  • [Cites] Clin Cancer Res. 2000 May;6(5):1655-63 [10815883.001]
  • [Cites] Am J Pathol. 2000 Aug;157(2):393-9 [10934144.001]
  • [Cites] Curr Eye Res. 2001 Sep;23 (3):157-65 [11803476.001]
  • [Cites] Oncogene. 2004 Mar 25;23(13):2298-304 [14755245.001]
  • [Cites] Neoplasma. 2006;53(4):343-6 [16830064.001]
  • [Cites] Int J Cancer. 2004 Jan 1;108(1):23-30 [14618611.001]
  • [Cites] Cancer Res. 2000 May 1;60(9):2547-54 [10811138.001]
  • [Cites] Cancer Res. 2004 Mar 1;64(5):1834-42 [14996747.001]
  • [Cites] Mod Pathol. 2002 Nov;15(11):1221-6 [12429802.001]
  • [Cites] J Cancer Res Clin Oncol. 1994;120(3):186-8 [8263017.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9530-5 [12886021.001]
  • [Cites] World J Gastroenterol. 2003 Apr;9(4):650-4 [12679903.001]
  • [Cites] Urology. 2002 Jan;59(1):150-4 [11796313.001]
  • [Cites] World J Urol. 2005 Feb;23(1):38-46 [15770517.001]
  • [Cites] BJU Int. 2003 Sep;92(4):463-9 [12930442.001]
  • [Cites] Int J Urol. 2001 Jul;8(7):337-49 [11442654.001]
  • [Cites] Cell Res. 2003 Feb;13(1):49-58 [12643349.001]
  • [Cites] Clin Cancer Res. 2001 Dec;7(12):4245-52 [11751526.001]
  • [Cites] J Urol. 2000 Sep;164(3 Pt 1):680-4 [10954628.001]
  • (PMID = 19757199.001).
  • [ISSN] 1532-2807
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Clusterin
  •  go-up   go-down


42. Jagannathan J, Oskouian RJ, Yeoh HK, Saulle D, Dumont AS: Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base; 2008 May;18(3):173-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Even though meningiomas are most often benign tumors, they can be locally invasive and can develop in locations that prevent surgical treatment.
  • Although the relationship between the various factors implicated in tumor development is unknown, understanding these factors will be critical in the treatment of malignant or surgically inaccessible tumors.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurochirurgie. 1966 May-Jun;12(3):361-71 [5962139.001]
  • [Cites] Humangenetik. 1975 Dec 23;30(4):343-8 [1218864.001]
  • [Cites] J Clin Endocrinol Metab. 1970 Aug;31(2):180-98 [4912771.001]
  • [Cites] Humangenetik. 1971;12(1):42-9 [5283371.001]
  • [Cites] Humangenetik. 1975;27(2):119-28 [1150234.001]
  • [Cites] Humangenetik. 1971;11(3):253-7 [5101664.001]
  • [Cites] Neuropathology. 2006 Dec;26(6):557-63 [17203593.001]
  • [Cites] Cancer Invest. 2006 Dec;24(8):727-33 [17162554.001]
  • [Cites] Expert Rev Neurother. 2006 Oct;6(10):1447-64 [17078786.001]
  • [Cites] Hum Pathol. 1998 Nov;29(11):1200-7 [9824096.001]
  • [Cites] Cancer Res. 1998 Aug 1;58(15):3226-30 [9699646.001]
  • [Cites] Cancer. 1998 Jun 1;82(11):2262-9 [9610708.001]
  • [Cites] J Neurosurg. 1998 May;88(5):870-3 [9576256.001]
  • [Cites] J Neurosurg. 1998 May;88(5):831-9 [9576250.001]
  • [Cites] Hum Pathol. 1998 Feb;29(2):140-5 [9490273.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] Cancer Res. 1998 Jan 1;58(1):29-33 [9426052.001]
  • [Cites] Acta Neuropathol. 1997 Nov;94(5):479-85 [9386781.001]
  • [Cites] J Pathol. 1997 Aug;182(4):380-4 [9306957.001]
  • [Cites] J Neurosurg. 1997 Sep;87(3):368-73 [9285600.001]
  • [Cites] Neurosurgery. 1997 Jun;40(6):1269-77 [9179901.001]
  • [Cites] Hum Pathol. 1997 Jul;28(7):779-85 [9224744.001]
  • [Cites] Neurosurgery. 1997 May;40(5):1016-26 [9149260.001]
  • [Cites] Hum Pathol. 1997 Apr;28(4):416-20 [9104940.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):271-5 [9007858.001]
  • [Cites] Oncogene. 1997 Feb 6;14(5):611-6 [9053860.001]
  • [Cites] J Neurosurg. 1997 Jan;86(1):113-20 [8988089.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:50-3 [8738495.001]
  • [Cites] Hum Genet. 1996 May;97(5):638-41 [8655145.001]
  • [Cites] Anticancer Res. 1996 Mar-Apr;16(2):717-23 [8687119.001]
  • [Cites] Cancer Genet Cytogenet. 1996 Nov;92(1):73-8 [8956876.001]
  • [Cites] Hum Genet. 1996 May;97(5):632-7 [8655144.001]
  • [Cites] Neurosurgery. 1995 Nov;37(5):937-46; discussion 946-7 [8559343.001]
  • [Cites] Cancer Genet Cytogenet. 1995 Sep;83(2):160-4 [7553588.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] Neurosurgery. 1995 Feb;36(2):365-73; discussion 373-4 [7731518.001]
  • [Cites] J Neurosurg. 1994 Sep;81(3):388-93 [8057146.001]
  • [Cites] Int J Cancer. 1995 Aug 22;64(4):223-8 [7657383.001]
  • [Cites] Biochem Pharmacol. 1987 Jul 1;36(13):2115-23 [3606629.001]
  • [Cites] J Neurosurg. 1985 Jan;62(1):18-24 [3964853.001]
  • [Cites] Int J Cancer. 1990 Jul 15;46(1):16-21 [2163990.001]
  • [Cites] J Neurosurg. 1990 May;72(5):786-91 [2182793.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(15):5710-4 [2377607.001]
  • [Cites] J Neurosurg. 1990 Aug;73(2):248-53 [2366081.001]
  • [Cites] Humangenetik. 1970;9(2):172-84 [5423930.001]
  • [Cites] Eye (Lond). 2004 Sep;18(9):954-8 [15037887.001]
  • [Cites] Neuropathology. 2003 Dec;23(4):275-81 [14719542.001]
  • [Cites] J Neurosurg. 2003 Oct;99(4):787-91 [14567620.001]
  • [Cites] Clin Cancer Res. 2003 Oct 1;9(12):4443-51 [14555517.001]
  • [Cites] Brain Pathol. 2001 Jul;11(3):296-305 [11414472.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Jun;60(6):628-36 [11398839.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1117-26 [11342575.001]
  • [Cites] Int J Cancer. 2001 May 15;92(4):551-4 [11304690.001]
  • [Cites] J Neurooncol. 2000 Dec;50(3):207-13 [11263500.001]
  • [Cites] J Neurosurg. 2001 Mar;94(3):487-92 [11235955.001]
  • [Cites] J Neurosurg. 2001 Jan;94(1):111-7 [11147878.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Oct;59(10):872-9 [11079777.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(5):493-505 [10898356.001]
  • [Cites] Hum Mol Genet. 2000 Jun 12;9(10):1495-500 [10888600.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Jul;59(7):614-20 [10901233.001]
  • [Cites] Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8 [10764269.001]
  • [Cites] Neurosurgery. 2000 Mar;46(3):692-702; discussion 702-3 [10719866.001]
  • [Cites] Neuropathol Appl Neurobiol. 2000 Feb;26(1):67-75 [10736068.001]
  • [Cites] N Engl J Med. 2000 Apr 20;342(16):1171-7 [10770982.001]
  • [Cites] Cancer. 1999 Dec 15;86(12):2649-58 [10594860.001]
  • [Cites] Int J Oncol. 2006 Jul;29(1):25-32 [16773181.001]
  • [Cites] Int J Oncol. 2006 Jun;28(6):1353-60 [16685436.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7121-6 [16103061.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Neurosurgery. 1999 Mar;44(3):579-87; discussion 587-8 [10069595.001]
  • [Cites] Cancer Res. 1995 Mar 1;55(5):1189-93 [7532545.001]
  • [Cites] Brain Pathol. 1995 Jan;5(1):11-4 [7767486.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):827-32 [7717450.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Apr 17;209(2):497-505 [7733917.001]
  • [Cites] Hum Genet. 1995 Mar;95(3):347-51 [7868131.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Apr;9(4):296-8 [7519053.001]
  • [Cites] Ophthalmologica. 1994;208(4):220-5 [7970552.001]
  • [Cites] Mol Carcinog. 1993;8(2):74-80 [8397797.001]
  • [Cites] J Neurosurg. 1993 Mar;78(3):456-62 [8433149.001]
  • [Cites] Childs Nerv Syst. 1991 Dec;7(8):432-6 [1665101.001]
  • [Cites] Semin Cancer Biol. 1992 Apr;3(2):89-96 [1378314.001]
  • [Cites] Cancer. 1992 Sep 15;70(6):1568-76 [1516008.001]
  • [Cites] Cancer Res. 1991 Nov 15;51(22):6202-5 [1933879.001]
  • [Cites] Cancer. 1991 Sep 15;68(6):1394-400 [1873791.001]
  • [Cites] Aust N Z J Surg. 1989 Nov;59(11):881-8 [2818349.001]
  • [Cites] Cancer. 1988 Nov 15;62(10):2139-44 [3052782.001]
  • [Cites] Cell. 1987 Jun 5;49(5):589-94 [2884037.001]
  • [Cites] J Med Genet. 1987 Sep;24(9):529-30 [3118032.001]
  • [Cites] Science. 1987 Apr 17;236(4799):317-9 [3105060.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2243-9 [2804914.001]
  • [Cites] Hereditas. 1984;101(1):103-13 [6490389.001]
  • [Cites] J Clin Oncol. 2003 Sep 1;21(17):3285-95 [12947064.001]
  • [Cites] Cancer Control. 2003 Mar-Apr;10(2):148-58 [12712009.001]
  • [Cites] Int J Cancer. 2003 May 10;104(6):728-34 [12640680.001]
  • [Cites] Cancer Causes Control. 2002 Sep;13(7):675-82 [12296515.001]
  • [Cites] J Neurosurg. 2002 Aug;97(2):441-9 [12186474.001]
  • [Cites] Neoplasia. 2002 Jul-Aug;4(4):304-11 [12082546.001]
  • [Cites] Genes Dev. 2002 May 1;16(9):1060-5 [12000789.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):183-90 [11958372.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):145-53 [11958368.001]
  • [Cites] J Neurooncol. 2001 Dec;55(3):149-58 [11859969.001]
  • [Cites] Int J Cancer. 2001 Oct 15;94(2):218-21 [11668501.001]
  • [Cites] Virchows Arch. 2001 Aug;439(2):176-84 [11561758.001]
  • [Cites] Int J Oncol. 2001 Sep;19(3):609-12 [11494043.001]
  • [Cites] Cancer Genet Cytogenet. 2001 Aug;129(1):88-91 [11520574.001]
  • [Cites] Clin Cancer Res. 2001 Aug;7(8):2269-76 [11489801.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):661-9 [11485924.001]
  • [Cites] Growth Horm IGF Res. 2001 Apr;11(2):84-91 [11472074.001]
  • [Cites] Clin Cancer Res. 1999 Feb;5(2):237-41 [10037170.001]
  • [Cites] Cancer. 1999 Jan 15;85(2):485-91 [10023719.001]
  • [Cites] Neurosurgery. 1998 Oct;43(4):890-8; discussion 898-9 [9766317.001]
  • [Cites] Humangenetik. 1972;14(2):167-9 [4112733.001]
  • [Cites] Hereditas. 1972;71(1):163-8 [4142025.001]
  • (PMID = 18978964.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2459329
  • [Keywords] NOTNLM ; Aggressive / atypical / biology / meningioma / treatment
  •  go-up   go-down


43. Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM: Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol; 2006 Nov;169(5):1767-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
  • Platelet-derived growth factor (PDGF) stimulates tumor growth and progression by affecting tumor and stromal cells.
  • In the HaCaT skin carcinogenesis model, transfection of immortal nontumorigenic and PDGF-receptor-negative HaCaT keratinocytes with PDGF-B induced formation of benign tumors.
  • In vivo, persistent PDGF-B expression induced enhanced tumor cell proliferation but only transiently stimulated stromal cell proliferation and angiogenesis.
  • The PDGF-induced, persistently increased expression of the hepatocyte growth factor by fibroblasts in vitro and in vivo was most probably responsible for enhanced epithelial cell proliferation and benign tumor formation.
  • Thus, by paracrine stimulation of the stroma, PDGF-BB induced epithelial hyperproliferation, thereby promoting tumorigenicity, whereas the time-limited activation of the stroma followed by stromal maturation provides a possible explanation for the benign tumor phenotype.
  • [MeSH-major] Epithelial Cells / drug effects. Epithelial Cells / pathology. Growth Substances / pharmacology. Neoplasms / pathology. Phenotype. Platelet-Derived Growth Factor / pharmacology. Stromal Cells / drug effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Development. 1999 Jun;126(14):3047-55 [10375497.001]
  • [Cites] Cancer Res. 1987 Jul 1;47(13):3425-9 [3034415.001]
  • [Cites] Cancer Res. 1999 Oct 1;59(19):5002-11 [10519415.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Aug;84(16):5763-7 [3039506.001]
  • [Cites] J Cell Biol. 1988 Mar;106(3):761-71 [2450098.001]
  • [Cites] Science. 1988 Jun 10;240(4858):1529-31 [2836952.001]
  • [Cites] EMBO J. 1988 Dec 1;7(12):3727-35 [2463166.001]
  • [Cites] Cancer Res. 1990 May 1;50(9):2840-7 [2183932.001]
  • [Cites] Cancer Res. 1990 Oct 1;50(19):6130-8 [1698118.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):2021-5 [1848018.001]
  • [Cites] Lab Invest. 1991 Mar;64(3):321-9 [1848332.001]
  • [Cites] Am J Pathol. 1992 Mar;140(3):639-48 [1372158.001]
  • [Cites] Lab Invest. 1992 Oct;67(4):529-34 [1434531.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):393-7 [8380638.001]
  • [Cites] J Clin Invest. 1993 May;91(5):2065-75 [8486774.001]
  • [Cites] Histochem J. 1993 Apr;25(4):251-66 [7684033.001]
  • [Cites] Am J Pathol. 1997 Aug;151(2):479-92 [9250160.001]
  • [Cites] Exp Cell Res. 1997 Aug 1;234(2):434-41 [9260914.001]
  • [Cites] Methods Mol Biol. 1997;75:305-11 [9276280.001]
  • [Cites] Nat Med. 1997 Nov;3(11):1222-7 [9359696.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1050-5 [9448283.001]
  • [Cites] Development. 1998 May;125(9):1591-8 [9521897.001]
  • [Cites] Histochem Cell Biol. 1998 Apr;109(4):349-57 [9562384.001]
  • [Cites] Exp Cell Res. 1998 Apr 10;240(1):1-6 [9570915.001]
  • [Cites] Circ Res. 1999 Feb 19;84(3):298-305 [10024303.001]
  • [Cites] Nat Rev Cancer. 2004 Nov;4(11):839-49 [15516957.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1294-305 [15735015.001]
  • [Cites] Exp Cell Res. 2005 Jul 15;307(2):292-304 [15950618.001]
  • [Cites] Exp Eye Res. 2006 Jan;82(1):74-80 [16198337.001]
  • [Cites] Blood. 2006 Mar 1;107(5):1896-902 [16322476.001]
  • [Cites] J Clin Invest. 1994 Jan;93(1):131-9 [7506710.001]
  • [Cites] J Cell Biol. 1994 May;125(4):917-28 [7514607.001]
  • [Cites] Int J Cancer. 1995 Jan 17;60(2):168-73 [7829210.001]
  • [Cites] Int J Cancer. 1997 Mar 28;71(1):42-8 [9096664.001]
  • [Cites] Int J Cancer. 2000 Feb 1;85(3):398-406 [10652433.001]
  • [Cites] Oncogene. 2000 Sep 7;19(38):4337-45 [10980609.001]
  • [Cites] FASEB J. 2001 Feb;15(2):447-57 [11156960.001]
  • [Cites] Semin Cancer Biol. 2001 Apr;11(2):97-104 [11322829.001]
  • [Cites] Bioessays. 2001 Jun;23(6):494-507 [11385629.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12072-7 [11593017.001]
  • [Cites] Lab Invest. 2001 Dec;81(12):1709-16 [11742041.001]
  • [Cites] J Biol Chem. 2002 Apr 5;277(14):12456-62 [11799124.001]
  • [Cites] Am J Pathol. 2002 Jul;161(1):135-43 [12107098.001]
  • [Cites] Microvasc Res. 2002 Nov;64(3):372-83 [12453432.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):486-97 [12492491.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):537-46 [12492495.001]
  • [Cites] Am J Pathol. 2003 Feb;162(2):533-46 [12547711.001]
  • [Cites] Lab Invest. 2003 Feb;83(2):163-73 [12594232.001]
  • [Cites] Nat Med. 2003 Jun;9(6):685-93 [12778167.001]
  • [Cites] Acta Biochim Pol. 2003;50(3):647-58 [14515146.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71 [15051869.001]
  • [Cites] J Cell Biol. 1982 Feb;92(2):584-8 [7061598.001]
  • [Cites] J Clin Invest. 1982 Apr;69(4):1046-9 [7076844.001]
  • [Cites] Cell. 1986 Jul 18;46(2):155-69 [3013421.001]
  • [Cites] N Engl J Med. 1986 Dec 25;315(26):1650-9 [3537791.001]
  • [Cites] Physiol Rev. 1999 Oct;79(4):1283-316 [10508235.001]
  • (PMID = 17071599.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Endostatins; 0 / Growth Substances; 0 / Platelet-Derived Growth Factor; 0 / Proto-Oncogene Proteins c-sis; 0 / RNA, Messenger; 0 / Vascular Endothelial Growth Factor A; 0 / platelet-derived growth factor BB; 67256-21-7 / Hepatocyte Growth Factor; EC 2.7.10.1 / Receptors, Platelet-Derived Growth Factor
  • [Other-IDs] NLM/ PMC1780216
  •  go-up   go-down


44. Tamura K, Aoyagi M, Wakimoto H, Tamaki M, Yamamoto K, Yamamoto M, Ohno K: Malignant transformation eight years after removal of a benign epidermoid cyst: a case report. J Neurooncol; 2006 Aug;79(1):67-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant transformation eight years after removal of a benign epidermoid cyst: a case report.
  • Malignant transformation of benign epidermoid cysts is rare and their prognosis remains poor.
  • A 56-year-old woman presented with left facial hypoesthesia and photophobia in the left eye.
  • She had undergone removal of a benign epidermoid cyst in the cerebellopontine angle 8 years previously.
  • She underwent removal again and the histopathologic diagnosis was squamous cell carcinoma.
  • The tumor shrank rapidly for 2 months after radiosurgery, but recurred 9 months later.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Cell Transformation, Neoplastic / pathology. Cerebellar Neoplasms / pathology. Cerebellopontine Angle / pathology. Epidermal Cyst / pathology
  • [MeSH-minor] Female. Gadolinium. Humans. Image Enhancement. Magnetic Resonance Imaging. Middle Aged. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Radiosurgery

  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1995 Jul-Aug;19(4):628-30 [7622698.001]
  • [Cites] No Shinkei Geka. 1987 Aug;15(8):851-8 [3323934.001]
  • [Cites] J Neurosurg. 2002 Nov;97(5):1237-43 [12450053.001]
  • [Cites] AJNR Am J Neuroradiol. 1991 Nov-Dec;12(6):1182-4 [1763747.001]
  • [Cites] J Neurosurg. 1983 Sep;59(3):538-41 [6886769.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1984;402(4):459-64 [6202051.001]
  • [Cites] J Neurosurg. 1965 Oct;23(4):384-93 [5853888.001]
  • [Cites] Neurol Med Chir (Tokyo). 1999 Jan;39(1):49-54 [10093462.001]
  • [Cites] Cancer. 1973 Mar;31(3):713-8 [4693599.001]
  • [Cites] Acta Neurochir (Wien). 1987;85(1-2):34-9 [3604769.001]
  • [Cites] Neurol Med Chir (Tokyo). 2003 Jun;43(6):275-80; discussion 281 [12870545.001]
  • [Cites] J Clin Neurosci. 2001 Nov;8(6):572-4 [11683611.001]
  • [Cites] Cancer. 2005 May 15;103(10):2143-53 [15816051.001]
  • [Cites] J Neurosurg. 1979 Jun;50(6):830-3 [312314.001]
  • [Cites] AJNR Am J Neuroradiol. 1989 Mar-Apr;10(2):351-6 [2494855.001]
  • [Cites] J Neurosurg. 1964 Dec;21:1051-8 [14279825.001]
  • [Cites] Neurosurgery. 1989 Apr;24(4):574-8 [2651960.001]
  • [Cites] No Shinkei Geka. 1990 Nov;18(11):1041-5 [2247198.001]
  • [Cites] J Neurosurg. 1981 Oct;55(4):654-6 [7277016.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1965 Jun;28:276-81 [14345685.001]
  • [Cites] J Neurosurg. 1987 Apr;66(4):618-20 [3559730.001]
  • [Cites] Neurol Med Chir (Tokyo). 1989 Jul;29(7):600-5 [2477760.001]
  • [Cites] N Engl J Med. 1977 Feb 3;296(5):271-6 [299778.001]
  • [Cites] J Comput Assist Tomogr. 1981 Jun;5(3):433-5 [6972395.001]
  • [Cites] Br J Neurosurg. 1993;7(5):565-9 [8267896.001]
  • [Cites] Br J Neurosurg. 1991;5(3):303-5 [1892574.001]
  • [Cites] Neurosurgery. 1995 Aug;37(2):329-32 [7477788.001]
  • [Cites] No Shinkei Geka. 1995 Oct;23(10):905-9 [7477700.001]
  • [Cites] Curr Opin Oncol. 1997 May;9(3):262-6 [9229149.001]
  • (PMID = 16583265.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] AU0V1LM3JT / Gadolinium
  •  go-up   go-down


45. Bianciotto C, Shields CL, Lally SE, Freire J, Shields JA: CyberKnife radiosurgery for the treatment of intraocular and periocular lymphoma. Arch Ophthalmol; 2010 Dec;128(12):1561-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lymphoma type was classified as extranodal marginal zone B-cell lymphoma in 7 eyes (50%), diffuse large B-cell lymphoma in 3 eyes (21%), follicular lymphoma in 2 eyes (14%), and benign reactive lymphoid hyperplasia in 2 eyes (14%).
  • Complete tumor resolution without local recurrence over a mean follow-up of 23 months was documented in all cases.
  • Radiation-associated adverse effects included mild dry eye in 2 patients and cataract in 1 patient with conjunctival lymphoma.
  • There was no radiation retinopathy or papillopathy, and visual acuity was preserved or improved in 13 eyes and decreased in 1 eye due to the presence of cataract.
  • [MeSH-major] Eye Neoplasms / surgery. Lymphoma, Non-Hodgkin / surgery. Pseudolymphoma / surgery. Radiosurgery

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21149780.001).
  • [ISSN] 1538-3601
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Ohnishi Y, Saika S, Yamanaka O, Okada Y, Shirai K, Miyamoto T, Nishikawa I, Tanaka T, Miyazaki K: [Investigation of mechanism of cell proliferation regulation and its clinical application]. Nippon Ganka Gakkai Zasshi; 2005 Dec;109(12):865-83; discussion 884
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cell proliferation and related cellular behavior in ocular neoplastic disease and in the healing process in ocular surgery or post-injury management, as well as new treatment strategy were investigated.
  • Cell proliferation-related signals were found to be activated to a greater extent in malignant ocular tumors than in benign tumor cells regardless of the similarity of simple histological findings.
  • Suppression of cell proliferation-related signals can be a new treatment for ocular neoplastic diseases.
  • [MeSH-minor] Animals. Eye Neoplasms / pathology. Eye Neoplasms / therapy. Gene Expression Regulation, Developmental. Genetic Therapy. Hedgehog Proteins. Humans. Ocular Physiological Phenomena. Trans-Activators / physiology. Wound Healing / genetics. Wound Healing / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16408488.001).
  • [ISSN] 0029-0203
  • [Journal-full-title] Nippon Ganka Gakkai zasshi
  • [ISO-abbreviation] Nippon Ganka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Hedgehog Proteins; 0 / Smad Proteins; 0 / Trans-Activators; 0 / Transcription Factor AP-1; 0 / Transforming Growth Factor beta
  • [Number-of-references] 77
  •  go-up   go-down


47. Tam ES, Chen EC, Nijhawan N, Harvey JT, Howarth D, Oestreicher JH: Solitary fibrous tumor of the orbit: a case series. Orbit; 2008;27(6):426-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor of the orbit: a case series.
  • PURPOSE: Solitary fibrous tumor (SFT) occurs rarely in the orbit.
  • We present four such cases, representing one of the largest case series reported to date of this rare orbital tumor.
  • METHOD: The four patients ranged from ages 20 to 50, all of whom presented with lid swelling or bulging in the involved eye.
  • All four patients underwent CT scan to confirm the diagnosis of an orbital mass, which was then excised.
  • One of these cases demonstrated residual tumor on follow-up CT scan, which remained unchanged at one-year follow-up.
  • No evidence of residual tumor was found in the other three cases, despite one having malignant pathology.
  • CONCLUSION: SFT is a rare and generally benign tumor of the orbit.
  • Immunohistochemical testing with CD34 is necessary to confirm the diagnosis.
  • Although en bloc tumor resection is the definitive treatment, residual tumor may remain stable for some time.
  • [MeSH-major] Fibroma / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD34 / analysis. Biomarkers, Tumor / analysis. Female. Humans. Male. Middle Aged. Neoplasm Proteins / analysis. Tomography, X-Ray Computed. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19085297.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; 0 / Vimentin
  •  go-up   go-down


48. Dégi R, Szabó A, Janáky M: [Experience in 13-year follow-up of a melanocytoma of the optic nerve head]. Magy Onkol; 2005;49(1):31-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirteen years ago, a 35-year-old woman was found on routine ocular examination to have a pigmented tumor in her right eye, adjacent to the optic nerve head.
  • Ultrasound examination revealed that the tumor diameter was 4.4 mm on the base and the maximal thickness was 2.7 mm.
  • There were several additional examinations (e.g. determination of the visual field, measurement of the intraocular pressure, detection of visually evoked potentials, CT scan and MRI examination) to exclude a benign tumor of similar appearance, The patient underwent ocular examination every year.
  • During the observation period a minor tumor enlargement occurred but there were no changes in the visual acuities.
  • The findings documented and illustrated here suggest that our methods were useful to differentiate the melanocytoma from a malignant melanoma, and no surgical interventions were needed to characterize or to remove the tumor.
  • [MeSH-major] Melanocytes. Melanoma / diagnosis. Optic Nerve Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Fluorescein Angiography. Follow-Up Studies. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15902331.001).
  • [ISSN] 0025-0244
  • [Journal-full-title] Magyar onkologia
  • [ISO-abbreviation] Magy Onkol
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


49. Al-Rashaed S, Abboud EB, Nowilaty SR: Characteristics of optic disc melanocytomas presenting with visual dysfunction. Middle East Afr J Ophthalmol; 2010 Jul;17(3):242-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE AND DESIGN: A retrospective review study was designed to describe five cases of optic disc melanocytomas with tumor-related visual impairment.
  • PARTICIPANTS: Five patients with optic disc melanocytoma presented with visual complaints to a tertiary eye hospital in Saudi Arabia.
  • MATERIALS AND METHODS: Demographic and clinical data were analyzed, including the results of ocular examination, lesion laterality, best-corrected Snellen visual acuity, pupillary reflex, visual field testing, color fundus photography, fundus fluorescein angiography, and ophthalmic ultrasound.
  • Case 1 had macular star edema with mild tumor enlargement, Case 2 had optic atrophy, Case 3 had juxtapapillary choroidal neovascular membrane with macular involvement, Case 4 had optic disc swelling with an enlarged blind spot, and Case 5 had a large altitudinal visual field defect.
  • CONCLUSION: Although melanocytomas of the optic disc tend to have a benign behavior with slow evolution and stable vision, they may adversely affect visual function through a variety of mechanisms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20844679.001).
  • [ISSN] 0975-1599
  • [Journal-full-title] Middle East African journal of ophthalmology
  • [ISO-abbreviation] Middle East Afr J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2934715
  • [Keywords] NOTNLM ; Melanocytoma / Optic Disc / Visual Function
  •  go-up   go-down


50. Tang DR, Shi XF, Sun FY, Zhao H, Jin YJ: [Clinical features and therapy of benign lymphoepithelial lesion]. Zhonghua Yan Ke Za Zhi; 2009 May;45(5):441-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical features and therapy of benign lymphoepithelial lesion].
  • OBJECTIVE: To report the clinical features of benign lymphoepithelial lesion and to further characterize recommendations for its therapy strategy.
  • Retrospective analyze the clinical characteristics, imaging features, pathological manifestation and the treatment effect from the clinical materials of 9 cases of patients with benign lymphoepithelial lesion presenting to Tianjin Eye Hospital from Jan 2006 to Dec 2007.
  • RESULTS: The 9 cases, in which 7 cases were female, 7 cases had lesions on both eyes, demonstrated unpainful swelling of the lacrimal glands and in different degree of salivary glands or had history of tumor resection of salivary glands.
  • Three patients were operated to excise the lacrimal gland masses due to imperfect treatment effect of medication or in order to make definite diagnosis.
  • The postoperative pathological results supported the diagnosis of benign lymphoepithelial lesion.
  • CONCLUSIONS: A clinical condition with swelling of either or both lacrimal gland and of any salivary gland, and accompanied with systemic relative diseases should be considered benign lymphoepithelial lesion.
  • Imaging examinations are helpful to definite diagnosis.
  • The definite diagnosis should be made through pathological examinations.
  • [MeSH-major] Mikulicz' Disease / diagnosis. Mikulicz' Disease / drug therapy

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19576068.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Glucocorticoids
  •  go-up   go-down


51. Fonseca Junior NL, Cha SB, Cartum J, Rehder JR: [Therapeutical effectiveness of interferon alpha in a child with craniofacial giant hemangioma: case report]. Arq Bras Oftalmol; 2008 May-Jun;71(3):423-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Eficácia terapêutica do interferon alfa em criança com hemangioma gigante craniofacial: relato de caso.
  • Hemangiomas are the most common benign tumors of infancy.
  • The diagnosis of these tumors is based on physical examination.
  • This is a case of a patient with three months of age, that presented since birth, a purplish tumor in the superior eyelid of the right eye, plain and purplish cutaneous lesions in the temporal and parietal right region.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Craniofacial Abnormalities / drug therapy. Facial Neoplasms / drug therapy. Hemangioma, Cavernous / drug therapy. Interferon-alpha / therapeutic use


52. Boonman ZF, van Mierlo GJ, Fransen MF, de Keizer RJ, Jager MJ, Melief CJ, Toes RE: Maintenance of immune tolerance depends on normal tissue homeostasis. J Immunol; 2005 Oct 1;175(7):4247-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we analyzed whether tolerance toward an intraocular tumor expressing a highly immunogenic CTL epitope is maintained, broken, or reverted into immunity in the event the anatomical integrity of the eye is lost.
  • Inoculation of tumor cells into the anterior chamber of the eye of naive B6 mice leads to progressive intraocular tumor growth, an abortive form of CTL activation in the tumor-draining submandibular lymph node, and systemic tolerance as evidenced by the inability of these mice to reject an otherwise benign tumor cell inoculum.
  • Loss of anatomical integrity of the eye as a consequence of phthisis resulted in loss of systemic tolerance and the emergence of effective antitumor immunity against an otherwise lethal tumor challenge.
  • Phthisis was accompanied by dendritic cell maturation and preceded the induction of systemic tumor-specific CTL immunity.
  • Our data show that normal tissue homeostasis and anatomical integrity is required for the maintenance of ocular tolerance and prevention of CTL-mediated immunity.
  • [MeSH-major] Eye Neoplasms / immunology. Homeostasis / immunology. Immune Tolerance / physiology
  • [MeSH-minor] Animals. Anterior Chamber / immunology. Antigen Presentation / immunology. Antigen-Presenting Cells / metabolism. Antigens, CD11c / metabolism. Antigens, Neoplasm / immunology. Cell Line, Transformed. Cell Line, Tumor. Cross-Priming / immunology. Mice. Mice, Inbred C57BL. Mice, Knockout. Mice, Transgenic. T-Lymphocytes, Cytotoxic / immunology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16177064.001).
  • [ISSN] 0022-1767
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD11c; 0 / Antigens, Neoplasm
  •  go-up   go-down


53. Schulze S, Hoerle S, Koop G, Barth PJ, Huegens-Penzel M, Strempel I: Intravascular papillary endothelial hyperplasia - a rare finding in the orbital region. Ophthalmologica; 2008;222(3):213-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intravascular papillary endothelial hyperplasia is a benign lesion of vascular origin.
  • We report the case of a 58-year-old woman sent to our clinic for surgery of an orbital fat prolapse at her right eye.
  • After MRI, a biopsy was carried out leading to the histological diagnosis of intravascular papillary endothelial hyperplasia.
  • The complete excision of the remaining tumor was performed 8 weeks later.
  • [MeSH-major] Endothelium, Vascular / pathology. Orbital Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Hyperplasia. Magnetic Resonance Imaging. Middle Aged. Ophthalmologic Surgical Procedures / methods

  • Genetic Alliance. consumer health - Intravascular papillary endothelial hyperplasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel
  • (PMID = 18497532.001).
  • [ISSN] 1423-0267
  • [Journal-full-title] Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
  • [ISO-abbreviation] Ophthalmologica
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


54. Shields CL, Eagle RC, Ip MS, Marr BP, Shields JA: Two discrete uveal melanomas in a child with ocular melanocytosis. Retina; 2006 Jul-Aug;26(6):684-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Two discrete uveal melanomas in a child with ocular melanocytosis.
  • OBJECTIVE: To describe a case of two uveal melanomas in a child with mild ocular melanocytosis.
  • Ocular oncology evaluation revealed mild sectorial scleral and uveal melanocytosis and an episcleral sentinel vessel superotemporally.
  • In the circumpapillary and macular region, tumor 1 was diffuse at 9.0 mm in base and 4.1 mm in thickness and with overlying subretinal fluid.
  • In the ciliary body, tumor 2 was discovered by transillumination and was 6.0 mm in base and 2.2 mm in thickness.
  • Tumor 1 was a mixed, predominantly epithelioid cell melanoma with active mitotic figures, and tumor 2 was a mixed, predominantly spindle cell melanoma.
  • The choroid between the melanomas showed only benign, dendritic melanocytes consistent with melanocytosis.
  • CONCLUSIONS: Ocular melanocytosis can predispose to one or multiple uveal melanomas.
  • [MeSH-major] Melanocytes / pathology. Melanoma / pathology. Melanosis / pathology. Neoplasms, Multiple Primary / pathology. Uveal Neoplasms / pathology
  • [MeSH-minor] Child. Eye Enucleation. Female. Humans

  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16829813.001).
  • [ISSN] 0275-004X
  • [Journal-full-title] Retina (Philadelphia, Pa.)
  • [ISO-abbreviation] Retina (Philadelphia, Pa.)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


55. Cho YJ, Won JB, Byeon SH, Yang WI, Koh HJ, Kwon OW, Lee SC: A choroidal schwannoma confirmed by surgical excision. Korean J Ophthalmol; 2009 Mar;23(1):49-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 30-year-old woman presented with a large nonpigmented intraocular mass of the choroid in the right eye and underwent surgical excision by sclerouvectomy.
  • Histologically, the tumor was composed of a mixture of cellular solid components (Antoni A) and loose myxoid components (Antoni B).
  • The tumor was eventually diagnosed as a schwannoma.
  • In the case of atypical findings for a malignant melanoma, a benign neoplasm should be included in the differential diagnosis.
  • [MeSH-major] Choroid / pathology. Choroid Neoplasms / diagnosis. Eye Enucleation / methods. Neurilemmoma / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ophthalmologica. 2000;214(2):156-60 [10720924.001]
  • [Cites] Ophthalmology. 1981 Dec;88(12):1322-9 [7322483.001]
  • [Cites] Br J Ophthalmol. 1987 Jan;71(1):34-40 [3545285.001]
  • [Cites] Acta Ophthalmol Scand. 2005 Dec;83(6):754-6 [16396657.001]
  • [Cites] Br J Ophthalmol. 1994 May;78(5):397-400 [8025076.001]
  • [Cites] Ophthalmology. 1995 Jun;102(6):918-23 [7777299.001]
  • [Cites] Can J Ophthalmol. 1995 Feb;30(1):37-41 [7780898.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1988;226(5):443-6 [3192095.001]
  • (PMID = 19337481.001).
  • [ISSN] 2092-9382
  • [Journal-full-title] Korean journal of ophthalmology : KJO
  • [ISO-abbreviation] Korean J Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2655748
  • [Keywords] NOTNLM ; Enucleation / Schwannoma / Sclerouvectomy
  •  go-up   go-down


56. Nuruddin M, Osmani M, Mudhar HS, Fernando M: Orbital lipofibromatosis in a child: a case report. Orbit; 2010 Dec;29(6):360-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Lipofibromatosis is a rare, benign, soft tissue tumor that typically involves extremities particularly in children.
  • Histopathological examination revealed that the lesion consisted of adipose tissue with fibroblastic elements, being consistent with a diagnosis of lipofibromatosis.
  • Diagnosis can be confirmed by histopathological analysis.
  • [MeSH-major] Fibroma / pathology. Lipoma / pathology. Orbital Neoplasms / pathology. Orbital Neoplasms / surgery
  • [MeSH-minor] Biopsy, Needle. Blepharoptosis / diagnosis. Blepharoptosis / etiology. Child. Female. Follow-Up Studies. Humans. Immunohistochemistry. Ophthalmologic Surgical Procedures / methods. Rare Diseases. Tomography, X-Ray Computed / methods. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21158580.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


57. Ethmoidal osteoid osteoma with orbital and intracranial extension - a case report. BMC Ear Nose Throat Disord; 2005 Mar 11;5:2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Osteoid osteoma is a benign bone neoplasm which is seen in the long bones of appendicular skeleton.
  • He presented with loss of vision in the left eye.
  • Radical excision of the tumor could thus be achieved through a craniofacial approach.
  • CONCLUSION: Although benign and rare, skull base osteoid osteoma can present with neurological deficit due to its mass effect and involvement of vital structures.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Neurosurg. 1998 Apr;12(2):173-5 [11013675.001]
  • [Cites] Am J Clin Pathol. 1975 Mar;63(3):391-6 [1115044.001]
  • [Cites] J Laryngol Otol. 1989 Jun;103(6):634-7 [2769039.001]
  • (PMID = 15760476.001).
  • [ISSN] 1472-6815
  • [Journal-full-title] BMC ear, nose, and throat disorders
  • [ISO-abbreviation] BMC Ear Nose Throat Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC555567
  •  go-up   go-down


58. Zhao P, Sun XL: [Clinical use of quantitative DNA pathologic examination in eye neoplasms]. Zhonghua Yan Ke Za Zhi; 2005 Oct;41(10):957-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical use of quantitative DNA pathologic examination in eye neoplasms].
  • Quantitative determination of DNA in tumor cells as an objective quantitative index reflecting biological behavior of tumor cells and has an important significance for distinguishing precancerous lesions, borderline tumors, benign and malignant tumors; and for estimating the malignant degree and prognosis.
  • This review introduces the study about DNA quantitative analysis used in clinical pathology of eye neoplasms.
  • [MeSH-major] DNA, Neoplasm / analysis. Eye Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16271190.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  • [Number-of-references] 27
  •  go-up   go-down


59. Sato Y, Takeda M, Yoshida F: [Three cases of combined hamartomas of the retina and retinal pigment epithelium with various clinical signs]. Nippon Ganka Gakkai Zasshi; 2007 Jan;111(1):26-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fluorescein angiography demonstrated hypofluorescence of the tumor in the early phase and hyperfluoresence of the capillaries of the tumor which were connected to retinal vessels.
  • Indocyanine green angiography demonstrated leakage of probable capillaries of the tumor.
  • CONCLUSIONS: Combined hamartoma is usually benign.
  • None of the patients developed tumor growth in our cases.
  • [MeSH-major] Hamartoma / pathology. Pigment Epithelium of Eye / pathology. Retinal Diseases / pathology

  • MedlinePlus Health Information. consumer health - Retinal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17305093.001).
  • [ISSN] 0029-0203
  • [Journal-full-title] Nippon Ganka Gakkai zasshi
  • [ISO-abbreviation] Nippon Ganka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


60. Kiss S, Gragoudas ES, Dryja TP, Jakobiec FA: Response of choroidal leiomyoma to treatment with proton beam radiation. Retin Cases Brief Rep; 2010;4(2):168-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Uveal leiomyoma is a rare, benign smooth muscle neoplasm usually diagnosed only after local resection or enucleation.
  • CASE REPORT: A 51-year-old woman presented with a choroidal mass in the left eye that was initially diagnosed as a choroidal melanoma.
  • The neoplasm was treated with a total of 70 cobalt gray equivalents of external proton beam radiation in 5 fractions over 7 days.
  • Biannual follow-up examinations over 3 years showed a funduscopically and ultrasonographically regressing tumor.
  • The left eye was enucleated approximately 3 years postradiotherapy because of progressively increasing pain secondary to elevated intraocular pressure from neovascular glaucoma.
  • Microscopic and immunohistochemical examination of the mass revealed a choroidal neoplasm expressing smooth muscle antigens consistent with a uveal leiomyoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25390394.001).
  • [ISSN] 1935-1089
  • [Journal-full-title] Retinal cases & brief reports
  • [ISO-abbreviation] Retin Cases Brief Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. John H, Whallett A, Quinlan M: Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha. Eye (Lond); 2007 Nov;21(11):1434-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha.
  • [MeSH-major] Conjunctival Diseases / drug therapy. Immunoglobulin G / therapeutic use. Immunosuppressive Agents / therapeutic use. Pemphigoid, Benign Mucous Membrane / drug therapy. Receptors, Tumor Necrosis Factor / therapeutic use. Tumor Necrosis Factor-alpha / antagonists & inhibitors

  • MedlinePlus Health Information. consumer health - Pemphigus.
  • Hazardous Substances Data Bank. Etanercept .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17693996.001).
  • [ISSN] 0950-222X
  • [Journal-full-title] Eye (London, England)
  • [ISO-abbreviation] Eye (Lond)
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Immunoglobulin G; 0 / Immunosuppressive Agents; 0 / Receptors, Tumor Necrosis Factor; 0 / Tumor Necrosis Factor-alpha; OP401G7OJC / Etanercept
  •  go-up   go-down


62. Yan XM, Chen Y, Li HL, Rong B, Yang SL: [Retrospective analysis of ocular cicatricial pemphigoid]. Zhonghua Yan Ke Za Zhi; 2010 Sep;46(9):781-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Retrospective analysis of ocular cicatricial pemphigoid].
  • OBJECTIVE: To analyze the clinical characterization of ocular cicatricial pemphigoid (OCP).
  • It was two to five years from the first time to see a doctor to definite diagnosis.
  • All of cases have been prescribed antibiotic eye drops for a long times, one case has been undergone three times trichiasis operation and made the disease progression.
  • Only in 1 case, there was slight increase of iron protein as tumor mark.
  • [MeSH-major] Diagnostic Errors. Pemphigoid, Benign Mucous Membrane


63. Lessell S, Kim JW, Hatton MP, Stemmer-Rachamimov A, Thiagalingham S, Rubin PA: Clinical without histopathological manifestations of inflammation in a patient with primary intraorbital optic nerve sheath meningioma. J Neuroophthalmol; 2007 Jun;27(2):104-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 28-year-old man with a biopsy-proven benign intraorbital optic nerve sheath meningioma developed recurrent clinical manifestations of ipsilateral retrobulbar inflammation 9 years after undergoing postoperative radiation therapy.
  • Debulking of the tumor 11 years after the original surgery again revealed no pathologic signs of inflammation.
  • Whether growth of tumor, surgery, radiation, or edema triggered the inflammatory manifestations is unclear.
  • [MeSH-major] Inflammation / complications. Meningeal Neoplasms / complications. Meningioma / complications. Optic Nerve Neoplasms / complications

  • Genetic Alliance. consumer health - Meningioma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17548993.001).
  • [ISSN] 1070-8022
  • [Journal-full-title] Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • [ISO-abbreviation] J Neuroophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Sampieri K, Amenduni M, Papa FT, Katzaki E, Mencarelli MA, Marozza A, Epistolato MC, Toti P, Lazzi S, Bruttini M, De Filippis R, De Francesco S, Longo I, Meloni I, Mari F, Acquaviva A, Hadjistilianou T, Renieri A, Ariani F: Array comparative genomic hybridization in retinoma and retinoblastoma tissues. Cancer Sci; 2009 Mar;100(3):465-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In retinoblastoma, two RB1 mutations are necessary for tumor development.
  • Array-comparative genomic hybridization was carried out in 18 eye samples, 10 from bilateral and eight from unilateral retinoblastoma patients.
  • The first group presented with younger age at diagnosis (mean 511 days) compared with the second group (mean 1606 days).
  • In one retinoma case ophthalmoscopically diagnosed as a benign lesion no rearrangements were detected, whereas the adjacent retinoblastoma displayed seven aberrations.
  • Genomic profiling indicated that the first retinoma was a pretumoral lesion, whereas the other represents a subclone of cells bearing 'benign' rearrangements overwhelmed by another subclone presenting aberrations with higher 'oncogenic' potential.
  • In summary, the present study shows that bilateral and unilateral retinoblastoma have different chromosomal instability that correlates with the age of tumor onset in unilateral cases.
  • [MeSH-major] Genes, Retinoblastoma. Retinal Neoplasms / genetics. Retinoblastoma / genetics. Retinoblastoma Protein / genetics

  • Genetic Alliance. consumer health - Retinoblastoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19183342.001).
  • [ISSN] 1349-7006
  • [Journal-full-title] Cancer science
  • [ISO-abbreviation] Cancer Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Anti-Idiotypic; 0 / Retinoblastoma Protein
  •  go-up   go-down


65. Ho CM, Lai HC, Huang SH, Chien TY, Lin MC, Chang SF: Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinoma. Eur J Clin Invest; 2010 Apr;40(4):310-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Specific tumour suppressor genes with promoter methylation in ovarian clear cell adenocarcinoma (OCCA) can be one important epigenetic mark distinguishing OCCA from ovarian serous adenocarcinoma (OSA), benign endometriotic cysts and normal ovarian epitheliums.
  • MATERIALS AND METHODS: Five OCCA cell lines, 63 cancer tissues (48 OCCA and 15 OSA), 10 benign endometriotic cysts and five normal ovarian epitheliums were analysed by methylation-specific PCR using pooled DNAs to determine the methylation status of the promoter of the target genes, including genes for secreted frizzled-related proteins (sFRP1 to 5), adenomatous polyposis coli (APC), retinoblastoma protein 1 (Rb1), breast cancer 1 gene (BRCA1), p14(ARF), p15(INK4b), p16(INK4a) and survivin.
  • RESULTS: The sFRP5 promoter was significantly methylated in all OCCA cell lines, with 64.6% in OCCA tissues compared with 13.3% in OSA, and 0% in benign endometriotic cysts and normal ovarian epitheliums (P < 0.0001).
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. DNA Methylation. Eye Proteins. Membrane Proteins. Ovarian Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor. Female. Gene Expression. Humans. Middle Aged. Polymerase Chain Reaction. Promoter Regions, Genetic. Risk Factors. Survival Rate


66. Horowitz G, Gil Z, Kavel O, Smith D, Sela M, Abargel A, Fliss D: [Surgical treatment of maxillary tumors]. Harefuah; 2010 Nov;149(11):704-7, 749
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this article is to review the indications, diagnosis and treatment of patients with maxillary tumors operated at Tel Aviv Sourasky Medical Center during the period 1999 - 2008.
  • METHODS: A total of 174 patients underwent surgery due to neoplasms originating in the maxillary sinus: 118 patients (68%) had malignant and 54 (32%) had benign tumors.
  • RESULTS: The most common malignancy was squamous cell carcinoma (40%), and the most common benign tumor was juvenile nasopharyngeal angiofibroma (36%).
  • In 9 cases, resection was extended to include the eye socket or base of skull, due to tumor invasion.
  • [MeSH-major] Maxillary Neoplasms / surgery
  • [MeSH-minor] Angiofibroma / mortality. Angiofibroma / surgery. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / surgery. Humans. Maxilla / surgery. Melanoma / mortality. Melanoma / surgery. Nasopharyngeal Neoplasms / mortality. Nasopharyngeal Neoplasms / surgery. Retrospective Studies. Sarcoma / mortality. Sarcoma / surgery. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21250410.001).
  • [ISSN] 0017-7768
  • [Journal-full-title] Harefuah
  • [ISO-abbreviation] Harefuah
  • [Language] heb
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Israel
  • [Chemical-registry-number] Nasopharyngeal carcinoma
  •  go-up   go-down


67. Benoit MM, Handzel O, McKenna MJ, Deschler DG: A 42-year-old man with facial nerve weakness and multiple recurrent pleomorphic adenoma. Otol Neurotol; 2010 Sep;31(7):1157-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To describe a case and discuss the differential diagnosis of facial nerve paresis presenting years after resection of multiple recurrent parotid pleomorphic adenoma.
  • MAIN OUTCOME MEASURES: Histopathologic diagnosis and treatment outcome.
  • RESULTS: Final diagnosis of recurrent pleomorphic adenoma causing compression of the facial nerve at the stylomastoid foramen.
  • CONCLUSION: Facial nerve weakness caused by a benign salivary gland tumor is rare.
  • [MeSH-major] Adenoma, Pleomorphic / complications. Facial Paralysis / etiology. Parotid Neoplasms / complications
  • [MeSH-minor] Adult. Humans. Immunosuppressive Agents / therapeutic use. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local. Temporal Bone / pathology. Tomography, X-Ray Computed

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20657328.001).
  • [ISSN] 1537-4505
  • [Journal-full-title] Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • [ISO-abbreviation] Otol. Neurotol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  •  go-up   go-down


68. Robinson JW, Brownstein S, Jordan DR, Hodge WG: Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature. Surv Ophthalmol; 2006 Sep-Oct;51(5):513-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature.
  • The woman was undergoing mitomycin C injections for ocular cicatricial pemphigoid, diagnosed in the same eye 2 years prior to identification of the neoplasm.
  • The tumor invaded the cornea, sclera, lacrimal gland, regional small nerves, and lymphatics, but did not show intraocular involvement.
  • [MeSH-major] Carcinoma, Mucoepidermoid / pathology. Conjunctival Neoplasms / pathology. Conjunctivitis / complications. Pemphigoid, Benign Mucous Membrane / complications
  • [MeSH-minor] Basement Membrane / pathology. Biopsy. Drug Therapy, Combination. Female. Fluorometholone / therapeutic use. Humans. Middle Aged. Mitomycin / therapeutic use. Neoplasm Invasiveness. Ofloxacin / therapeutic use


69. Paglia D, Dubielzig RR, Kado-Fong HK, Maggs DJ: Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms. Am J Vet Res; 2009 Oct;70(10):1284-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.
  • OBJECTIVE: To determine whether cyclooxygenase-2 (COX-2) is expressed in benign or malignant canine uveal melanocytic neoplasms and whether expression correlates with malignancy.
  • SAMPLE POPULATION: Tissue sections from 71 globes; 57 with benign (n = 15), malignant (34), or mixed (8) uveal melanocytic neoplasms; 10 with nonneoplastic disease; and 4 with no abnormalities.
  • RESULTS: Expression of COX-2 was detected in all but 5 globes, all of which contained neoplasms.
  • Expression of COX-2 was detected in regions infiltrated by neoplasia in 21 globes; however, definitive labeling of tumor cells was detected in only 2 of those.
  • Expression of COX-2 was detected in the ciliary body of more globes with uveal malignant melanoma (20/34) than in those without disease (1/4), with nonneoplastic disease (4/10), or with melanocytoma (3/15) or mixed neoplasms (3/8).
  • CONCLUSIONS AND CLINICAL RELEVANCE: Canine globes with uveal melanocytic neoplasia appeared to express COX-2 in similar sites and with similar intensity as globes without neoplasia.
  • Differentiation of benign from malignant canine uveal melanocytic neoplasms was not possible.
  • [MeSH-major] Cyclooxygenase 2 / metabolism. Dog Diseases / metabolism. Eye Neoplasms / veterinary. Uvea / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19795944.001).
  • [ISSN] 0002-9645
  • [Journal-full-title] American journal of veterinary research
  • [ISO-abbreviation] Am. J. Vet. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


70. Perez DE, Pires FR, Almeida OP, Kowalski LP: Epithelial lacrimal gland tumors: a clinicopathological study of 18 cases. Otolaryngol Head Neck Surg; 2006 Feb;134(2):321-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: Epithelial lacrimal gland tumors are mainly PA and ACC, and malignancies are more common than benign tumors.
  • Although ACC presented typically with advanced clinical stage, 33% of the patients survived without tumor recurrence or metastasis.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Adenoid Cystic / pathology. Eye Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16455384.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


71. Hirschbein MJ, Collins S, Jean WC, Chang SD, Adler JR Jr: Treatment of intraorbital lesions using the Accuray CyberKnife system. Orbit; 2008;27(2):97-105
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: This retrospective, non-comparative, interventional case series included 16 patients (6 women and 10 men) with lesions located wholly within the orbit.
  • Thirteen cases involved tumors (31% benign and 69% malignant), two cases presented with chronic orbital inflammation and one patient had intraorbital tissue growth secondary to Graves disease.
  • The main outcome measures analyzed were change in tumor/neoplasm size, pain, visual field preservation and visual acuity, which were followed for up to 15 months.
  • RESULTS: Twelve patients had a postoperative MRI, which revealed either a decrease or stabilization of tumor size.
  • In the five lymphoma cases there was complete disappearance of the tumor.
  • CONCLUSIONS: Staged CyberKnife radiosurgery is an effective option for the treatment of intraorbital lesions that controls tumor size, relieves pain, and preserves vision.
  • [MeSH-major] Orbital Neoplasms / radiotherapy. Orbital Neoplasms / surgery. Radiosurgery / instrumentation. Surgery, Computer-Assisted / instrumentation

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18415869.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contrast Media; 4419T9MX03 / Iohexol
  •  go-up   go-down


72. Dériot JB, Ledoux-Pilon A, Pilon F, Ravel A, Déchelotte P, Rigal D, Chiambaretta F: [Solitary fibrous tumor of the orbit: an unusual cause of unilateral proptosis. Case report with a review of the literature]. J Fr Ophtalmol; 2005 Nov;28(9):999-1005
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Solitary fibrous tumor of the orbit: an unusual cause of unilateral proptosis. Case report with a review of the literature].
  • [Transliterated title] Tumeur fibreuse solitaire de l'orbite: une cause inhabituelle d'exophtalmie unilatérale. A propos d'un cas avec revue de la littérature.
  • BACKGROUND: The solitary fibrous tumor (SFT) is a spindle-cell tumor that very rarely involves the orbit.
  • CASE: A 72-year-old woman presented a conjunctival inflammation of the right eye developing over 5 months with progressive proptosis.
  • Histological examination of the lesion removed by anterior orbitotomy confirmed the diagnosis of the SFT of the orbit.
  • DISCUSSION: The diagnosis of SFT is histological.
  • It is a mesenchymal tumor.
  • Immunohistochemically, the tumor cells are strongly positive for CD34 and vimentin.
  • CONCLUSION: The SFT of the orbit is a very rare and generally benign tumor.
  • [MeSH-major] Exophthalmos / etiology. Orbital Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16395228.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 36
  •  go-up   go-down


73. Wali UK, Al-Mujaini A: Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol; 2010 Sep;3(3):117-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It represents 1-5.5% of eyelid malignancies and is considered to be the third most common eyelid malignancy after basal cell and squamous cell carcinomas, although few reports placed this tumor as second most common after basal cell carcinoma.
  • A delay in diagnosis, which can be attributed primarily to ability of this tumor to masquerade as more benign conditions, often leads to inappropriate management with increased morbidity and mortality rates.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21120046.001).
  • [ISSN] 0974-7842
  • [Journal-full-title] Oman journal of ophthalmology
  • [ISO-abbreviation] Oman J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2992157
  • [Keywords] NOTNLM ; Moh’s / nodular / pagetoid / sebaceous gland carcinoma
  •  go-up   go-down


74. Wilkins-Port CE, Ye Q, Mazurkiewicz JE, Higgins PJ: TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. Cancer Res; 2009 May 1;69(9):4081-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The phenotypic switching called epithelial-to-mesenchymal transition is frequently associated with epithelial tumor cell progression from a comparatively benign to an aggressive, invasive malignancy.
  • TGF-beta in the tumor microenvironment promotes invasive traits largely through reprogramming gene expression, which paradoxically supports matrix-disruptive as well as stabilizing processes. ras-transformed HaCaT II-4 keratinocytes undergo phenotypic changes typical of epithelial-to-mesenchymal transition, acquire a collagenolytic phenotype, and effectively invade collagen type 1 gels as a consequence of TGF-beta1 + EGF stimulation in a three-dimensional physiologically relevant model system that monitors collagen remodeling.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Sci. 2000 Jan;113 Pt 2:227-35 [10633074.001]
  • [Cites] J Surg Res. 2008 May 1;146(1):32-42 [17543340.001]
  • [Cites] J Interferon Cytokine Res. 2001 Jan;21(1):11-9 [11177576.001]
  • [Cites] Jpn J Cancer Res. 2001 Mar;92(3):257-68 [11267935.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6686-91 [11390996.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20 [11448356.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):117-29 [11586292.001]
  • [Cites] Biochemistry (Mosc). 2002 Jan;67(1):92-8 [11841344.001]
  • [Cites] Nat Rev Cancer. 2002 Jun;2(6):442-54 [12189386.001]
  • [Cites] Cancer Detect Prev. 2002;26(3):222-8 [12269770.001]
  • [Cites] J Biol Chem. 2002 Nov 22;277(47):45154-61 [12192005.001]
  • [Cites] Lab Invest. 2003 Mar;83(3):435-48 [12649344.001]
  • [Cites] Mol Cell Biochem. 2003 Nov;253(1-2):269-85 [14619979.001]
  • [Cites] Curr Opin Cell Biol. 2003 Dec;15(6):740-6 [14644200.001]
  • [Cites] J Biol Chem. 2004 May 21;279(21):22595-604 [15001579.001]
  • [Cites] Exp Eye Res. 2004 Aug;79(2):263-74 [15325573.001]
  • [Cites] Oncogene. 2008 Apr 17;27(18):2626-34 [17982486.001]
  • [Cites] Clin Exp Metastasis. 2008;25(6):593-600 [18286378.001]
  • [Cites] Oncogene. 2008 Aug 14;27(35):4841-53 [18427549.001]
  • [Cites] Ann Oncol. 2008 Sep;19(9):1566-72 [18503039.001]
  • [Cites] J Immunol. 2004 Sep 15;173(6):3605-11 [15356104.001]
  • [Cites] Curr Opin Cell Biol. 2004 Oct;16(5):558-64 [15363807.001]
  • [Cites] Ann N Y Acad Sci. 1990;580:225-32 [2186691.001]
  • [Cites] Exp Cell Res. 1991 Mar;193(1):93-100 [1995305.001]
  • [Cites] Matrix Suppl. 1992;1:368-74 [1480062.001]
  • [Cites] J Biol Chem. 1993 Aug 15;268(23):17341-7 [8349617.001]
  • [Cites] Cancer Res. 1994 Sep 1;54(17):4671-5 [8062262.001]
  • [Cites] Mol Carcinog. 1994 Sep;11(1):19-28 [7916986.001]
  • [Cites] EMBO J. 1995 Jul 3;14(13):2969-77 [7621813.001]
  • [Cites] Cell. 1996 Aug 23;86(4):531-42 [8752208.001]
  • [Cites] Biochem J. 1996 Dec 1;320 ( Pt 2):659-64 [8973581.001]
  • [Cites] Cell Growth Differ. 1997 Feb;8(2):243-50 [9040946.001]
  • [Cites] Br J Cancer. 1998 Mar;77(5):724-30 [9514050.001]
  • [Cites] Nat Med. 1998 Aug;4(8):923-8 [9701244.001]
  • [Cites] Mol Carcinog. 1998 Nov;23(3):144-58 [9833775.001]
  • [Cites] Biochem J. 1999 Apr 1;339 ( Pt 1):167-75 [10085241.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5242-54 [15371548.001]
  • [Cites] Neoplasia. 2005 Jan;7(1):57-66 [15720817.001]
  • [Cites] Br J Cancer. 2005 Jun 20;92(12):2171-80 [15928670.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Jul;3(7):493-503 [15967008.001]
  • [Cites] J Clin Invest. 2005 Jul;115(7):1714-23 [15937546.001]
  • [Cites] J Cell Biochem. 2005 Aug 1;95(5):918-31 [15861394.001]
  • [Cites] Exp Cell Res. 2006 Apr 15;312(7):1093-105 [16457817.001]
  • [Cites] Front Biosci. 2006;11:3100-20 [16720379.001]
  • [Cites] Arthritis Rheum. 2006 Oct;54(10):3244-53 [17009259.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2107-14 [17119035.001]
  • [Cites] Exp Cell Res. 2007 Jul 1;313(11):2367-77 [17467690.001]
  • [Cites] Eur Urol. 2007 Sep;52(3):791-7 [17207914.001]
  • [Cites] Oncogene. 2008 Jan 24;27(5):614-28 [17637750.001]
  • [Cites] Biochem Pharmacol. 2000 Oct 15;60(8):1091-9 [11007946.001]
  • (PMID = 19383899.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / T32-HL07194; United States / NIGMS NIH HHS / GM / GM57242; United States / NIGMS NIH HHS / GM / GM057242-11; United States / NHLBI NIH HHS / HL / T32 HL007194; United States / NIGMS NIH HHS / GM / R01 GM057242; United States / NIGMS NIH HHS / GM / R01 GM057242-11
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Collagen Type I; 0 / Plasminogen Activator Inhibitor 1; 0 / SERPINE1 protein, human; 0 / Transforming Growth Factor beta1; 62229-50-9 / Epidermal Growth Factor; EC 3.4.21.7 / Fibrinolysin; EC 3.4.24.22 / Matrix Metalloproteinase 10; EC 3.4.24.7 / Matrix Metalloproteinase 1
  • [Other-IDs] NLM/ NIHMS242077; NLM/ PMC2962982
  •  go-up   go-down


75. Segal A, Segal N, Gal A, Tumuluri K: Mucinous sweat gland adenocarcinoma of the eyelid - current knowledge of a rare tumor. Orbit; 2010 Dec;29(6):334-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous sweat gland adenocarcinoma of the eyelid - current knowledge of a rare tumor.
  • In 12(21.8%) patients a lesion with a benign diagnosis was previously excised from the same location.
  • In 2 of them histological re-examination resulted in a diagnosis of MSA.
  • Recurrence of the tumor was reported in 14(30%) patients.
  • CONCLUSIONS: MSA is a rare tumor of the eyelid with no clinically distinguishing features.
  • The tumor may extend into the orbit and metastasize regionally.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Eyelid Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Sweat Gland Neoplasms / pathology
  • [MeSH-minor] Aged. Aged, 80 and over. Biopsy, Needle. Female. Follow-Up Studies. Humans. Immunohistochemistry. Male. Mohs Surgery / methods. Neoplasm Staging. Rare Diseases. Risk Assessment. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21158574.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


76. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J: Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature. Strahlenther Onkol; 2006 Nov;182(11):635-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
  • PURPOSE: To analyze own long-term results with fractionated stereotactic radiotherapy (FSRT) in patients with benign meningiomas of the cavernous sinus and to review the literature on these rare lesions.
  • PATIENTS AND METHODS: 57 patients were treated with FSRT for benign meningiomas of the cavernous sinus between 01/1990 and 12/2003 at the authors' institution.
  • Overall local tumor control was 100%.
  • 39/57 patients had stable disease based on CT/MRI, while 18/57 had a partial remission of tumor volume.
  • There was one patient with recurrent hyperlacrimation of one eye on the side of the irradiated meningioma.
  • CONCLUSION: These data demonstrate that FSRT is an effective and safe treatment modality for local control of benign cavernous sinus meningiomas with a minimal risk of significant late toxicity.
  • [MeSH-major] Cavernous Sinus. Dose Fractionation. Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy
  • [MeSH-minor] Follow-Up Studies. Humans. Magnetic Resonance Imaging. Neoplasm Recurrence, Local / radiotherapy. Radiosurgery. Radiotherapy Dosage. Radiotherapy Planning, Computer-Assisted. Remission Induction. Safety. Stereotaxic Techniques. Time Factors. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17072520.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 43
  •  go-up   go-down


77. Kim BH, Henderson BA: Intraocular choristoma. Semin Ophthalmol; 2005 Oct-Dec;20(4):223-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although it is regarded as a benign tumor, it grows progressively and can decrease visual function.
  • [MeSH-major] Choristoma / diagnosis. Eye Diseases / diagnosis
  • [MeSH-minor] Animals. Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16352493.001).
  • [ISSN] 0882-0538
  • [Journal-full-title] Seminars in ophthalmology
  • [ISO-abbreviation] Semin Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 54
  •  go-up   go-down


78. Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT: Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Am J Ophthalmol; 2005 Aug;140(2):193-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DESIGN: Interventional non-randomized clinical study.
  • Two were imaged before treatment of their primary tumor.
  • The mean time from initial diagnosis to metastasis was 47 months (range 0 to 154).
  • PET/computed tomography imaging also detected benign lesions of the bone and lymph nodes in three patients (15%).
  • [MeSH-major] Choroid Neoplasms / pathology. Choroid Neoplasms / radionuclide imaging. Melanoma / radionuclide imaging. Melanoma / secondary. Positron-Emission Tomography / methods. Whole-Body Counting / methods
  • [MeSH-minor] Aged. Aged, 80 and over. Bone Neoplasms / radionuclide imaging. Bone Neoplasms / secondary. Female. Fluorodeoxyglucose F18. Humans. Liver Neoplasms / radionuclide imaging. Liver Neoplasms / secondary. Lung Neoplasms / radionuclide imaging. Lung Neoplasms / secondary. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Radiopharmaceuticals. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15992753.001).
  • [ISSN] 0002-9394
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


79. Popovic MB, Diezi M, Kuchler H, Abouzeid H, Maeder P, Balmer A, Munier FL: Trilateral retinoblastoma with suprasellar tumor and associated pineal cyst. J Pediatr Hematol Oncol; 2007 Jan;29(1):53-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trilateral retinoblastoma with suprasellar tumor and associated pineal cyst.
  • Trilateral retinoblastoma (TRb) is a well-known syndrome associating hereditary retinoblastoma (Rb) with an intracranial neuroblastic tumor arising usually in the pineal region, rarely at the suprasellar or parasellar site.
  • It develops in most cases after diagnosis of Rb.
  • Pineal cysts have recently been reported as a benign variant of TRb.
  • We report the unusual presentation of a TRb in a 12-month-old boy with extensive bilateral Rb, a voluminous suprasellar tumor, pineal cyst, and leptomeningeal disease.
  • [MeSH-major] Central Nervous System Cysts / radiography. Eye Neoplasms / radiography. Meningeal Neoplasms / radiography. Pineal Gland / radiography. Retinoblastoma / radiography


80. Cohen VM, Shields CL, Furuta M, Shields JA: Vitreous seeding from retinal astrocytoma in three cases. Retina; 2008 Jun;28(6):884-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: An asymptomatic 8-year-old boy (Case 1) presented with a white juxtapapillary retinal tumor and extensive overlying large vitreous seeds.
  • Fine-needle aspiration biopsy (FNAB) confirmed the diagnosis of benign retinal astrocytoma.
  • A 5-year-old boy (Case 2) presented with a large, multilobulated, tan juxtapapillary retinal tumor.
  • Histopathologic analysis of the enucleated globe supported the diagnosis of retinal astrocytoma.
  • The tumor height increased from 2.5 mm to 5.5 mm, and total retinal detachment developed.
  • After enucleation, the diagnosis of retinal astrocytoma was confirmed.
  • CONCLUSIONS: Retinal astrocytoma can produce vitreous seeds, sometimes associated with tumor growth.
  • Care should be taken to exclude the diagnosis of retinoblastoma.
  • [MeSH-major] Astrocytoma / secondary. Eye Neoplasms / secondary. Neoplasm Seeding. Retinal Neoplasms / pathology. Vitreous Body / pathology
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Eye Enucleation. Female. Humans. Male. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18536607.001).
  • [ISSN] 0275-004X
  • [Journal-full-title] Retina (Philadelphia, Pa.)
  • [ISO-abbreviation] Retina (Philadelphia, Pa.)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


81. Kernt M, Schaller UC, Stumpf C, Ulbig MW, Kampik A, Neubauer AS: Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap). Clin Ophthalmol; 2010;4:829-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Choroidal melanoma is the most prevalent primary neoplasia among malignant ocular tumors, and metastasis often occurs before the primary tumor is diagnosed.
  • We investigated the imaging properties of clinically diagnosed melanocytic choroidal tumors using a nonmydriatic ultra-wide-field scanning laser ophthalmoscope (SLO) with two laser wavelengths to distinguish benign from malignant lesions.
  • METHODS: In a consecutive series of 49 patients with clinically diagnosed melanocytic choroidal tumors in one eye, 29 had established melanoma (defined by proven growth on repeated US follow-up) and 20 had nevi (defined by no malignancy according to clinical, US, and growth characteristics for at least 2 years).
  • Measurements of the tumor base using the Optomap software were compared with US B-scan measurements.
  • RESULTS: Measurements of tumor base correlated well between SLO and US with r = 0.61 (T-direction) and r = 0.51 (L-direction).
  • CONCLUSIONS: In this first, limited series, nonmydriatic SLO imaging with two laser wavelengths permitted to differentiate malignant ocular tumors from nonmalignant lesions with high diagnostic accuracy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AMA Arch Ophthalmol. 1959 Aug;62(2):196-202 [13669796.001]
  • [Cites] Trans Am Ophthalmol Soc. 1995;93:259-75; discussion 275-9 [8719682.001]
  • [Cites] Br J Ophthalmol. 1995 Oct;79(10):892-9 [7488576.001]
  • [Cites] Ophthalmology. 1994 Apr;101(4):710-6; discussion 717 [8152767.001]
  • [Cites] Arch Ophthalmol. 1988 Mar;106(3):381-5 [3278703.001]
  • [Cites] Ophthalmic Res. 1988;20(5):298-303 [3186201.001]
  • [Cites] Ophthalmology. 1986 May;93(5):661-5 [3725325.001]
  • [Cites] Int Ophthalmol Clin. 1980 Summer;20(2):71-92 [6995393.001]
  • [Cites] Int Ophthalmol Clin. 1979 Winter;19(4):127-210 [395120.001]
  • [Cites] Cancer. 1979 Mar;43(3):883-8 [427730.001]
  • [Cites] Arch Ophthalmol. 1977 Apr;95(4):593-7 [849182.001]
  • [Cites] Am J Ophthalmol. 1977 Mar;83(3):299-323 [848534.001]
  • [Cites] Am J Ophthalmol. 1973 Jul;76(1):19-25 [4717339.001]
  • [Cites] Acta Ophthalmol (Copenh). 1975 Mar;53(2):139-52 [1173995.001]
  • [Cites] Bibl Ophthalmol. 1975;(83):141-54 [1131210.001]
  • [Cites] Cancer. 1967 Apr;20(4):493-507 [6019824.001]
  • [Cites] Arch Ophthalmol. 1966 Dec;76(6):784-96 [5924936.001]
  • [Cites] Circulation. 2010 Mar 30;121(12):1459-60 [20351304.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2823-8 [18408179.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1581-90 [16636839.001]
  • [Cites] Cancer Control. 2004 Sep-Oct;11(5):304-9 [15377989.001]
  • [Cites] Can J Ophthalmol. 2004 Jun;39(4):351-7 [15327099.001]
  • [Cites] Can J Ophthalmol. 2004 Jun;39(4):343-50 [15327098.001]
  • [Cites] Curr Opin Ophthalmol. 2002 Jun;13(3):135-41 [12011680.001]
  • [Cites] Ophthalmology. 2000 Aug;107(8):1443-9 [10919885.001]
  • [Cites] Arch Ophthalmol. 2000 Mar;118(3):360-4 [10721958.001]
  • (PMID = 20689737.001).
  • [ISSN] 1177-5483
  • [Journal-full-title] Clinical ophthalmology (Auckland, N.Z.)
  • [ISO-abbreviation] Clin Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Other-IDs] NLM/ PMC2915871
  • [Keywords] NOTNLM ; choroidal melanoma / imaging / nevus / ultra-wide-field scanning laser ophthalmoscopy
  •  go-up   go-down


82. Zhou L, Chen X, Huang W, Li K, Zhang X, Wang W: [Surgical management of minor salivary gland tumors]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Nov;21(21):963-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: Retrospective analysis of 54 cases with minor salivary gland tumor operated in our hospital from 1997 to 2004.
  • Among the remaining 38 patients, 2 patients with nasal cavity adenoid cystic carcinoma died of tumor recurrence 2 and 3 years after the surgery respectively, one patient with laryngeal myoepithelial carcinoma died of tumor recurrence 3 years after the surgery and one patient with paranasal sinus mucoepidermoid carcinoma died of recurrence 17 months after the surgery.
  • Two patients with paranasal sinus adenoid cystic carcinoma recurred after the primary surgery and were survived without tumor after salvage surgery.
  • The other patients survived with no tumor recurrence.
  • The treatment policy for benign tumors is simple tumor excision, while that for malignant tumors is surgery combined with pre- or post-operative radiation therapy.
  • Complete surgical resection of tumor masses and tumor free margin is essential for successful treatment of malignant minor salivary gland tumors.
  • [MeSH-major] Salivary Gland Neoplasms / surgery. Salivary Glands, Minor / surgery

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18309648.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


83. Kinoshita S, Kakizaki H, Iwaki M, Hara K: [Two cases of dermolipoma]. Nippon Ganka Gakkai Zasshi; 2007 Dec;111(12):965-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Dermolipoma is an uncommon benign tumor, congenitally occurring on the conjunctiva, and may be present at other sites.
  • The appearance of dermolipoma closely resembles orbital fat prolapse and limbal dermoid, and therefore it is necessary to take this into account in diagnosis.
  • CASE REPORT: The first case was a 52-year-old female patient referred for the treatment of an orbital fat prolapse in her right eye.
  • Another case, an 8-year-old female patient, was referred for the treatment of a bulbar conjunctival tumor in her left eye.
  • In both cases, dermolipoma was suspected because the tumor did not show in the limbus and it did not change in size even when the eyeball was pressed.
  • CONCLUSIONS: If the special features of dermolipoma are understood, it is easy to distinguish this tumor from other disorders.
  • [MeSH-minor] Child. Conjunctival Neoplasms / congenital. Conjunctival Neoplasms / surgery. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18186219.001).
  • [ISSN] 0029-0203
  • [Journal-full-title] Nippon Ganka Gakkai zasshi
  • [ISO-abbreviation] Nippon Ganka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


84. Andrei S, Zemba M, Bratulescu M, Dobrescu N, Cucu B, Popescu A, Cuzino D, Curea M: [Cataract surgery in an eye with intraocular tumor]. Oftalmologia; 2005;49(4):41-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cataract surgery in an eye with intraocular tumor].
  • [Transliterated title] Consecintele efectuării operatiei de cataractă pe un ochi cu tumoră intraoculară--caz clinic.
  • This case present the consequences of performing the cataract surgery on an eye with intraocular tumor, pointing the importance of a detailed and complete examination, even for the benign and easy to diagnostic diseases.
  • [MeSH-major] Cataract Extraction. Choroid Neoplasms / diagnosis. Eye / pathology. Melanoma / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Eye Enucleation. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Eye Care.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16524125.001).
  • [ISSN] 1220-0875
  • [Journal-full-title] Oftalmologia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Oftalmologia
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


85. Badr MA, Elkhamary SM, Al Sabbagh S, Al Turjoman A: Bilateral Optic Nerve Sheath Meningioma with Intracanalicular and Intracranial Component in a 25-year-old Saudi Patient. Middle East Afr J Ophthalmol; 2008 Jul;15(3):138-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A meningioma is a benign neoplastic lesion from meningothelial cells of the meninges.
  • The diagnosis was delayed more than six years from initial symptoms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):37-58, ix [10026728.001]
  • [Cites] AJNR Am J Neuroradiol. 1999 Nov-Dec;20(10):1963-9 [10588126.001]
  • [Cites] Bull Soc Belge Ophtalmol. 2000;275:73-8 [10853310.001]
  • [Cites] Radiology. 2003 Jun;227(3):718-9 [12773677.001]
  • [Cites] Arch Ophthalmol. 2006 Mar;124(3):379-85 [16534058.001]
  • [Cites] Eye (Lond). 1987;1 ( Pt 5):597-602 [3446540.001]
  • [Cites] Radiology. 1998 Jan;206(1):57-63 [9423652.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 May;17(5):901-6 [8733965.001]
  • [Cites] Surv Ophthalmol. 2001 Jul-Aug;46(1):56-8 [11525791.001]
  • [Cites] Arch Ophthalmol. 1980 Jan;98(1):149-51 [7352862.001]
  • [Cites] Neurosurgery. 1978 Jul-Aug;3(1):68-74 [683499.001]
  • [Cites] Ophthalmology. 1984 Feb;91(2):137-55 [6709328.001]
  • [Cites] Ophthalmology. 1984 Nov;91(11):1313-26 [6514296.001]
  • [Cites] Mayo Clin Proc. 1978 Feb;53(2):84-92 [621962.001]
  • [Cites] Trans Am Ophthalmol Soc. 1972;70:490-528 [4663681.001]
  • [Cites] Arch Ophthalmol. 1974 Jan;91(1):24-8 [4202807.001]
  • [Cites] Arch Ophthalmol. 2002 Nov;120(11):1505-8 [12427064.001]
  • [Cites] Ophthalmology. 2003 Oct;110(10):2019-30 [14522782.001]
  • [Cites] Am J Ophthalmol. 1949 Dec;32(12):1663-80, illust [15399170.001]
  • (PMID = 21369471.001).
  • [ISSN] 0974-9233
  • [Journal-full-title] Middle East African journal of ophthalmology
  • [ISO-abbreviation] Middle East Afr J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3040919
  • [Keywords] NOTNLM ; MRI / meningioma / optic nerve sheath meningioma / optic nerve tumor
  •  go-up   go-down


86. Hałoń A, Błazejewska M, Sabri H, Rabczyński J: [Tumors and tumor-like lesions of eyelids collected at Department of Pathological Anatomy, Wroclaw Medical University, between 1946 and 1999]. Klin Oczna; 2005;107(7-9):475-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Tumors and tumor-like lesions of eyelids collected at Department of Pathological Anatomy, Wroclaw Medical University, between 1946 and 1999].
  • PURPOSE: To determine the histopathological, epidemiological and clinical characteristics of benign, malignant and tumor-like lesions of the eyelid collected in Department of Pathological Anatomy, Wrocław Medical University.
  • MATERIAL AND METHODS: Department of Pathological Anatomy, Wrocław Medical University, has been collecting data of all tumors and tumor-like lesions of the eye and ocular adnexa diagnosed at the department during the 54-year interval from 1946 through 1999.
  • RESULTS: There were 4818 cases of the eye and ocular adnexa lesions diagnosed at the department since 1946 and 1999, what made up 0.262% of all diagnosed cases.
  • The eyelids were the most common localization of malignant tumors (39.9% cases of all eye regions).
  • The incidence cohort of all eyelid lesions included 2031 cases what made up 42.15% of all diagnosed lesions within the eye and it's adnexa.
  • Benign tumors were the most common lesions (n=1262; 62.2%).
  • Almost 2/3 of all tumor-like lesions in both genders were cysts including atheromas.
  • CONCLUSIONS: Benign eyelid tumors compose the majority of all eyelid lesions.
  • The eyelids are the most common localization of malignant tumors within the eye and it's adnexa.
  • Basal cell carcinoma is the most common malignant eyelid tumor.
  • [MeSH-major] Carcinoma / epidemiology. Eyelid Neoplasms / epidemiology. Papilloma / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16417001.001).
  • [ISSN] 0023-2157
  • [Journal-full-title] Klinika oczna
  • [ISO-abbreviation] Klin Oczna
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


87. Livaoĝlu M, Cakir E, Karaçal N: Large orbital osteoma arising from orbital roof: Excision through an upper blepharoplasty incision. Orbit; 2009;28(2-3):200-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoma is the most common benign tumor of facial bony structure.
  • The patient's ophtalmological examination revealed; only light perception due to the severe amblyopia and posterior capsular opacification in the right eye, and complete visual acuity in the left.
  • His left eye was proptotic and directed to downward lateral gaze position.
  • There were not any postoperative complications and all ocular symptoms in the left eye were resolved after 1 month.
  • [MeSH-major] Orbital Neoplasms / diagnosis. Orbital Neoplasms / surgery. Osteoma / diagnosis. Osteoma / surgery
  • [MeSH-minor] Biopsy, Needle. Blepharoplasty / methods. Blepharoptosis / diagnosis. Blepharoptosis / etiology. Follow-Up Studies. Humans. Imaging, Three-Dimensional. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Ophthalmologic Surgical Procedures / methods. Risk Assessment. Time Factors. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19839914.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


88. Kodama S, Okamoto T, Suzuki M: Sinonasal schwannoma with new bone formation expressing bone morphogenic protein. Int J Otolaryngol; 2010;2010:154948
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schwannoma is a benign tumor that arises from the sheath of myelinated nerve fibers and may occur in any part of the body.
  • The tumor was successfully treated by endoscopic sinus surgery, and the patient showed no evidence of recurrence 24 months postoperatively.
  • Immunohistochemically, the tumor expressed bone morphogenic protein 4, indicating a possible role of this protein in the new bone formation in schwannomas.

  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 1999 Dec;(369):296-301 [10611885.001]
  • [Cites] Acta Neurochir (Wien). 2002 Apr;144(4):395-9 [12021889.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Oct 26;362(3):550-3 [17719560.001]
  • [Cites] Am J Rhinol. 2007 Sep-Oct;21(5):607-10 [17999798.001]
  • [Cites] Genes Dev. 1996 Jul 1;10(13):1580-94 [8682290.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2000;257(7):402-5 [11052256.001]
  • [Cites] Eye (Lond). 2004 Feb;18(2):218; discussion 218-9 [14762430.001]
  • [Cites] Otolaryngol Head Neck Surg. 2006 Feb;134(2):343-4 [16455392.001]
  • [Cites] Am J Rhinol. 2006 Jan-Feb;20(1):64-71 [16539297.001]
  • [Cites] J Laryngol Otol. 2008 Jun;122(6):598-602 [17705894.001]
  • [Cites] Spine J. 2009 May;9(5):e19-23 [19138570.001]
  • [Cites] Otolaryngol Head Neck Surg. 2001 Jul;125(1):96-7 [11458222.001]
  • [Cites] Rhinology. 2001 Sep;39(3):169-72 [11721510.001]
  • [Cites] Rhinology. 1988 Sep;26(3):217-9 [3143145.001]
  • [Cites] Cancer. 1994 Aug 1;74(3):842-7 [8039112.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Jan 15;25(2):268-72 [10685494.001]
  • (PMID = 21197441.001).
  • [ISSN] 1687-921X
  • [Journal-full-title] International journal of otolaryngology
  • [ISO-abbreviation] Int J Otolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3010644
  •  go-up   go-down


89. Prey S, Robert PY, Drouet M, Sparsa A, Roux C, Bonnetblanc JM, Bédane C: Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept. Acta Derm Venereol; 2007;87(1):74-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
  • [MeSH-major] Eye Diseases / drug therapy. Immunoglobulin G / therapeutic use. Immunosuppressive Agents / therapeutic use. Pemphigoid, Benign Mucous Membrane / drug therapy. Receptors, Tumor Necrosis Factor / therapeutic use
  • [MeSH-minor] Aged, 80 and over. Etanercept. Female. Humans. Treatment Outcome. Tumor Necrosis Factor-alpha / antagonists & inhibitors

  • Genetic Alliance. consumer health - Cicatricial Pemphigoid.
  • Genetic Alliance. consumer health - Ocular cicatricial pemphigoid.
  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • MedlinePlus Health Information. consumer health - Pemphigus.
  • Hazardous Substances Data Bank. Etanercept .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17225020.001).
  • [ISSN] 0001-5555
  • [Journal-full-title] Acta dermato-venereologica
  • [ISO-abbreviation] Acta Derm. Venereol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Immunoglobulin G; 0 / Immunosuppressive Agents; 0 / Receptors, Tumor Necrosis Factor; 0 / Tumor Necrosis Factor-alpha; OP401G7OJC / Etanercept
  •  go-up   go-down


90. Bodack MI: Ptosis and cranial nerve IV palsy reveal juvenile myasthenia gravis. Optometry; 2009 Jul;80(7):342-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In both cases, these conditions can be benign and require no further workup.
  • If a patient presents with multiple neurologic signs, a sudden onset eye turn, or ptosis, the patient must undergo a workup to rule out a pathologic etiology, specifically a brain tumor.
  • If the results of the neuroimaging are normal, and the findings are variable, myasthenia gravis should be considered, and additional testing should be ordered to assist in the diagnosis.
  • Diagnosis of myasthenia gravis was made based on clinical presentation and response to ice pack testing.
  • CONCLUSIONS: Although rare, myasthenia should be considered a diagnosis in children who present with variable ptosis or strabismus.
  • [MeSH-major] Blepharoptosis / etiology. Myasthenia Gravis / complications. Myasthenia Gravis / diagnosis. Strabismus / etiology. Trochlear Nerve Diseases / etiology
  • [MeSH-minor] Child, Preschool. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Neurology. Optometry. Referral and Consultation

  • Genetic Alliance. consumer health - Myasthenia gravis.
  • Genetic Alliance. consumer health - Ptosis.
  • MedlinePlus Health Information. consumer health - Myasthenia Gravis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Optometry. 2009 Sep;80(9):466
  • (PMID = 19545846.001).
  • [ISSN] 1558-1527
  • [Journal-full-title] Optometry (St. Louis, Mo.)
  • [ISO-abbreviation] Optometry
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Hamdi R, De Korvin H, Speeg-Schatz C, Szwarcberg J: [Combined hamartoma of the retina and retinal pigment epithelium. Four case studies]. J Fr Ophtalmol; 2006 Mar;29(3):e6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Hamartome combiné de l'épithélium pigmentaire et de la rétine. A propos de 4 cas.
  • This study aimed to demonstrate the advantages of early diagnosis and regular monitoring.
  • OBSERVATIONS: We report a series of four children followed between 2001 and 2004 with combined hamartoma of the retina and retinal pigment epithelium, with age of diagnosis ranging from 3 months to 8 years.
  • DISCUSSION: Combined hamartoma of the retina and retinal pigment epithelium is probably a congenital tumor whose pathogenesis has not yet been elucidated.
  • The diagnosis is clinical and the patient can be thoroughly examined by retinal angiography and optical coherence tomography (OCT).
  • In this disorder, it is important to eliminate retinoblastoma and malignant melanoma of the choroid, showing the advantage of radiological exploration.
  • This tumor can progress in spite of its benign character.
  • [MeSH-major] Hamartoma. Pigment Epithelium of Eye. Retinal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16557165.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


92. Charbel Issa P, Meyer-ter-Vehn T, Guthoff R, Klink T, Holz FG, Löffler K: [Malignant melanoma of the conjunctiva]. Klin Monbl Augenheilkd; 2008 Jul;225(7):663-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Malignant melanoma of the conjunctiva is a rare tumour.
  • Early disease stages may be difficult to distinguish from benign lesions such as pigmented nevi or primary acquired melanosis.
  • Two female patients (84 and 85 years old, respectively) presented with a pigmented tumor close to the limbus with surrounding conjunctival pigmentation and involvement of the cornea.
  • RESULTS: Following complete excision of the tumour, conjunctival malignant melanoma arising from primary acquired melanosis was diagnosed histologically.
  • Subsequent treatment with mitomycin C eye drops was initiated.
  • There was no recurrence of the tumor within the follow-up period (24 and 6 months).
  • [MeSH-major] Conjunctival Neoplasms / epidemiology. Conjunctival Neoplasms / pathology. Melanoma / epidemiology. Melanoma / pathology
  • [MeSH-minor] Aged, 80 and over. Diagnosis, Differential. Female. Humans. Incidence

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18642211.001).
  • [ISSN] 1439-3999
  • [Journal-full-title] Klinische Monatsblätter für Augenheilkunde
  • [ISO-abbreviation] Klin Monbl Augenheilkd
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


93. Singh AD, Kaiser PK, Sears JE: Choroidal hemangioma. Ophthalmol Clin North Am; 2005 Mar;18(1):151-61, ix
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Choroidal hemangioma is an uncommon benign vascular tumor of the choroid that can be circumscribed or diffuse.
  • Diffuse choroidal hemangiomas are usually evident at birth and generally occur as a part of neuro-oculo-cutaneous hemangiomatosis (Sturge-Weber syndrome).
  • [MeSH-major] Choroid Neoplasms / pathology. Hemangioma / pathology
  • [MeSH-minor] Choroid / pathology. Choroid / ultrasonography. Combined Modality Therapy. Diagnosis, Differential. Fluorescein Angiography. Fundus Oculi. Humans. Magnetic Resonance Imaging. Prognosis. Sturge-Weber Syndrome / diagnosis. Sturge-Weber Syndrome / therapy

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15763200.001).
  • [ISSN] 0896-1549
  • [Journal-full-title] Ophthalmology clinics of North America
  • [ISO-abbreviation] Ophthalmol Clin North Am
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 55
  •  go-up   go-down


94. Müller CS, Tilgen W, Kutzner H, Pföhler C: Recurring mixed-type neurothekeoma of the face. Dermatoendocrinol; 2009 Jul;1(4):220-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Neurothekeomas are rare, benign neoplasms, typically occurring in younger patients with a remarkable predilection for the female population.
  • The rarity of this unusual skin tumor in daily routine histopathologic findings prompted the following report.
  • OBSERVATION: We report a 17-year-old girl with an asymptomatic nodule at the inner angle of the left eye with slow progression in size within 12 months to 1 cm in diameter.
  • Multiple treatments with laser surgery were performed and yielded no persistent remission of the tumor.
  • Histopathologic examination revealed a non-encapsulated dermal tumor, composed of multiple, closely situated medium-sized nodules, separated by a myxoid collagenrich stroma, without epidermal alteration.
  • In summary, due to the histoarchitecture and immunoprofile of the tumor, a mixed-type cellular neurothekeoma was diagnosed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1998 May;32(5):414-22 [9639116.001]
  • [Cites] Pathologe. 1999 Mar;20(2):98-109 [10320997.001]
  • [Cites] Mod Pathol. 2004 Feb;17(2):230-4 [14685254.001]
  • [Cites] Am J Surg Pathol. 2007 Mar;31(3):329-40 [17325474.001]
  • [Cites] Histopathology. 1992 May;20(5):397-404 [1587488.001]
  • [Cites] Dermatol Surg. 2005 Jun;31(6):720-2 [15996430.001]
  • [Cites] Am J Surg Pathol. 2007 Jul;31(7):1103-14 [17592278.001]
  • (PMID = 20592794.001).
  • [ISSN] 1938-1980
  • [Journal-full-title] Dermato-endocrinology
  • [ISO-abbreviation] Dermatoendocrinol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2835878
  • [Keywords] NOTNLM ; cellular / nerve sheath tumor / neurothekeoma / skin / soft tissue tumor
  •  go-up   go-down


95. Godeiro KD, Frota AC, Antecka E, Odashiro AN, Maloney S, Fernandes B, Burnier MN Jr: Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane. J Carcinog; 2006;5:21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prostate-specific membrane antigen (PSMA) is a type II membrane glycoprotein expressed in benign and malignant prostatic tissues, in some non-prostatic tissues, and in the endothelium of tumor-associated neovasculature of non-prostatic neoplasm.
  • Some studies have suggested that the expression of PSMA is restricted to endothelium from tumor-associated neovasculature and might be stimulated by some tumor-secreted angiogenic factors.
  • However, no previous study demonstrating PSMA expression in non-related tumor neovasculature, such as CNVM, has been performed to date.
  • CONCLUSION: The absence of PSMA expression in non-tumoral neovasculature supports the theory, previously suggested, that endothelial cell PSMA expression may be stimulated by one or more tumor-secreted angiogenic factors.
  • Angiogenesis is very important in neoplasia and the endothelial expression of PSMA in tumor-associated neovasculature may represent a target for antineovasculature-based therapy.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1999 Jul 1;59(13):3192-8 [10397265.001]
  • [Cites] Clin Cancer Res. 1996 Sep;2(9):1445-51 [9816319.001]
  • [Cites] Urology. 2001 Jun;57(6):1179-83 [11377343.001]
  • [Cites] Br J Ophthalmol. 2001 Oct;85(10):1153-7 [11567955.001]
  • [Cites] Mol Vis. 2002 Apr 21;8:119-26 [11979237.001]
  • [Cites] Surv Ophthalmol. 2003 May-Jun;48(3):257-93 [12745003.001]
  • [Cites] Am J Ophthalmol. 2004 Mar;137(3):496-503 [15013874.001]
  • [Cites] Eye (Lond). 2006 Mar;20(3):341-6 [15905873.001]
  • [Cites] Ophthalmology. 1992 Jun;99(6):933-43 [1630784.001]
  • [Cites] Cancer Res. 1990 Oct 1;50(19):6423-9 [1698122.001]
  • [Cites] Anticancer Res. 1987 Sep-Oct;7(5B):927-35 [2449118.001]
  • [Cites] Ophthalmology. 1984 Dec;91(12):1603-8 [6084226.001]
  • [Cites] Cancer Res. 1993 Jan 15;53(2):227-30 [8417812.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):749-53 [8570628.001]
  • [Cites] Arch Ophthalmol. 1997 Feb;115(2):242-50 [9046260.001]
  • [Cites] Ophthalmology. 1995 Oct;102(10):1450-60 [9097791.001]
  • [Cites] Cancer Res. 1997 Sep 1;57(17):3629-34 [9288760.001]
  • [Cites] Clin Cancer Res. 1997 Jan;3(1):81-5 [9815541.001]
  • [Cites] Clin Cancer Res. 1999 Oct;5(10):2674-81 [10537328.001]
  • (PMID = 16911781.001).
  • [ISSN] 1477-3163
  • [Journal-full-title] Journal of carcinogenesis
  • [ISO-abbreviation] J Carcinog
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1560378
  •  go-up   go-down


96. Rodrigues EB, Shields CL, Eagle RC Jr, Marr BP, Shields JA: Solitary intraosseous orbital myofibroma in four cases. Ophthal Plast Reconstr Surg; 2006 Jul-Aug;22(4):292-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To report four pediatric cases of a bone-destructive orbital tumor that proved to be a benign solitary intraosseous myofibroma.
  • The diagnosis was also supported by immunohistochemical studies showing positive immunoreactivity for vimentin and smooth muscle actin.
  • CONCLUSIONS: Myofibroma is a benign tumor that can occur in the orbital bony wall of children.
  • [MeSH-major] Myofibroma / pathology. Orbital Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16855503.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


97. Broggi M, Darbar A, Teo C: The value of endoscopy in the total resection of pineocytomas. Neurosurgery; 2010 Sep;67(3 Suppl Operative):ons159-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A series of 15 patients (11 females, 4 males; mean age, 48 years) with histological diagnosis of pineocytoma were retrospectively reviewed.
  • The endoscope was used at various times throughout the case and consistently at the end to evaluate any possible residual tumor.
  • There was only one patient with permanent neurological deficit (disconjugate eye movements).
  • Two patients (13%) had transient poor sleep pattern, 5 patients (33%) had transient disconjugate eye movements, and 2 patients (13%) had transient short-term memory disturbance.
  • In 6 cases (40%), the endoscope was able to detect residual tumor located either behind the Vein of Galen or attached to the undersurface of the corpus callosum.
  • Residual tumor was then resected using a 30 degrees endoscope and dedicated angled endoscopic instruments.
  • With total removal of these histologically benign tumors patients may enjoy extended progression-free survival without adjuvant radiotherapy.
  • [MeSH-major] Brain Neoplasms / surgery. Endoscopy / methods. Neurosurgery / methods. Pineal Gland / surgery. Pinealoma / surgery. Ventriculostomy / methods

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20679933.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Sokol JA, Clark JD, Lee HB, Nunery WR: Pigmented epithelioid melanocytoid tumor of the ocular adnexa. J Pediatr Ophthalmol Strabismus; 2010;47 Online:e1-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pigmented epithelioid melanocytoid tumor of the ocular adnexa.
  • An 8-year-old girl with a history of microphthalmia in the right eye presented with a left medial upper eyelid mass with a dark blue-green nodule that could be seen through the skin but did not appear to involve the overlying epidermis.
  • A biopsy demonstrated a pigmented epithelioid melanocytoid tumor with rare mitoses arising in association with a congenital nevus and positive margins.
  • Due to the pathological findings, the patient underwent excision of the tumor with 5-mm margins and a sentinel lymph node biopsy.
  • The re-excision of the upper eyelid margins demonstrated residual benign congenital melanocytic nevus, but did not reveal residual melanocytic lesion.
  • The parotid sentinel node biopsy revealed benign and cytologically mature nevus nests in the capsule and septa, but there was no evidence of involvement with the pigmented epithelioid melanocytoid tumor.
  • [MeSH-major] Eyelid Neoplasms / pathology. Nevus, Epithelioid and Spindle Cell / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010, SLACK Incorporated.
  • (PMID = 21162462.001).
  • [ISSN] 1938-2405
  • [Journal-full-title] Journal of pediatric ophthalmology and strabismus
  • [ISO-abbreviation] J Pediatr Ophthalmol Strabismus
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


99. Cordero Coma M, Yilmaz T, Foster CS: Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Acta Ophthalmol Scand; 2007 Nov;85(7):753-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid.
  • PURPOSE: The presence of tumour necrosis factor-alpha (TNF-alpha) in conjunctivae affected by ocular cicatricial pemphigoid (OCP) was investigated.
  • [MeSH-major] Conjunctiva / metabolism. Conjunctivitis, Allergic / metabolism. Pemphigoid, Benign Mucous Membrane / metabolism. Tumor Necrosis Factor-alpha / metabolism


100. Kim HJ, McCormick SA, Nath S, Moskowitz B, Milman T: Melanocytic nevi of the tarsal conjunctiva: clinicopathologic case series with review of literature. Ophthal Plast Reconstr Surg; 2010 Nov-Dec;26(6):438-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Clinicopathologic series of 4 cases diagnosed at the New York Eye and Ear Infirmary between January 1990 and April 2009.
  • Biopsy, therefore, is prudent as histopathology alone allows documentation of the benign nature of these lesions.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Eyelid Neoplasms / pathology. Nevus, Pigmented / pathology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Child, Preschool. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20683369.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down






Advertisement